Telepsychiatry during COVID-19: Understanding the rules

Article Type
Changed
Thu, 08/26/2021 - 16:07
Display Headline
Telepsychiatry during COVID-19: Understanding the rules

In addition to affecting our personal lives, coronavirus disease 2019 (COVID-19) has altered the way we practice psychiatry. Telepsychiatry—the delivery of mental health services via remote communication—is being used to replace face-to-face outpatient encounters. Several rules and regulations governing the provision of care and prescribing have been temporarily modified or suspended to allow clinicians to more easily use telepsychiatry to care for their patients. Although these requirements are continually changing, here I review some of the telepsychiatry rules and regulations clinicians need to understand to minimize their risk for liability.

Changes in light of COVID-19

In March 2020, the Centers for Medicare & Medicaid Services (CMS) released guidance that allows Medicare beneficiaries to receive various services at home through telehealth without having to travel to a doctor’s office or hospital.1 Many commercial insurers also are allowing patients to receive telehealth services in their home. The US Department of Health & Human Services Office for Civil Rights, which enforces the Health Insurance Portability and Accountability Act (HIPAA), reported in March 2020 that it will not impose penalties for not complying with HIPAA requirements on clinicians who provide good-faith telepsychiatry during the COVID-19 crisis.2

Clinicians who want to use audio or video remote communication to provide any type of telehealth services (not just those related to COVID-19) should use “non-public facing” products.2 Non-public facing products (eg, Skype, WhatsApp video call, Zoom) allow only the intended parties to participate in the communication.3 Usually, these products employ end-to-end encryption, which allows only those engaging in communication to see and hear what is transmitted.3 To limit access and verify the participants, these products also support individual user accounts, login names, and passwords.3 In addition, these products usually allow participants and/or “the host” to exert some degree of control over particular features, such as choosing to record the communication, mute, or turn off the video or audio signal.3 When using these products, clinicians should enable all available encryption and privacy modes.2

“Public-facing” products (eg, Facebook Live, TikTok, Twitch) should not be used to provide telepsychiatry services because they are designed to be open to the public or allow for wide or indiscriminate access to the communication.2,3 Clinicians who desire additional privacy protections (and a more permanent solution) should choose a HIPAA-compliant telehealth vendor (eg, Doxy.me, VSee, Zoom for Healthcare) and obtain a Business Associate Agreement with the vendor to ensure data protection and security.2,4

Regardless of the product, obtain informed consent from your patients that authorizes the use of remote communication.4 Inform your patients of any potential privacy or security breaches, the need for interactions to be conducted in a location that provides privacy, and whether the specific technology used is HIPAA-compliant.4 Document that your patients understand these issues before using remote communication.4

How licensing requirements have changed

As of March 31, 2020, the CMS temporarily waived the requirement that out-of-state clinicians be licensed in the state where they are providing services to Medicare beneficiaries.5 The CMS waived this requirement for clinicians who meet the following 4 conditions5,6:

  • must be enrolled in Medicare
  • must possess a valid license to practice in the state that relates to his/her Medicare enrollment
  • are furnishing services—whether in person or via telepsychiatry—in a state where the emergency is occurring to contribute to relief efforts in his/her professional capacity
  • are not excluded from practicing in any state that is part of the nationally declared emergency area.

Note that individual state licensure requirements continue to apply unless waived by the state.6 Therefore, in order for clinicians to see Medicare patients via remote communication under the 4 conditions described above, the state also would have to waive its licensure requirements for the type of practice for which the clinicians are licensed in their own state.6 Regarding commercial payers, in general, clinicians providing telepsychiatry services need a license to practice in the state where the patient is located at the time services are provided.6 During the COVID-19 pandemic, many governors issued executive orders waiving licensure requirements, and many have accelerated granting temporary licenses to out-of-state clinicians who wish to provide telepsychiatry services to the residents of their state.4

Continue to: Prescribing via telepsychiatry

 

 

Prescribing via telepsychiatry

Effective March 31, 2020 and lasting for the duration of COVID-19 emergency declaration, the Drug Enforcement Agency (DEA) suspended the Ryan Haight Online Pharmacy Consumer Protection Act of 2008, which requires clinicians to conduct initial, in-person examinations of patients before they can prescribe controlled substances electronically.6,7 The DEA suspension allows clinicians to prescribe controlled substances after conducting an initial evaluation via remote communication. In addition, the DEA waived the requirement that a clinician needs to hold a DEA license in the state where the patient is located to be able to prescribe a controlled substance electronically.4,6 However, you still must comply with all other state laws and regulations for prescribing controlled substances.4

Staying informed

Although several telepsychiatry rules and regulations have been modified or suspended during the COVID-19 pandemic, the standard of care for services rendered via telepsychiatry remains the same as services provided via face-to-face encounters, including patient evaluation and assessment, treatment plans, medication, and documentation.4 Clinicians can keep up-to-date on how practicing telepsychiatry may evolve during these times by using the following resources from the American Psychiatric Association:

References

1. Centers for Medicare and Medicaid Services. COVID-19: President Trump expands telehealth benefits for Medicare beneficiaries during COVID-19 outbreak. https://www.cms.gov/outreach-and-educationoutreachffsprovpartprogprovider-partnership-email-archive/2020-03-17. Published March 17, 2020. Accessed May 6, 2020.
2. US Department of Health & Human Services. Notification of enforcement discretion for telehealth remote communications during the COVID-19 nationwide public health emergency. https://www.hhs.gov/hipaa/for-professionals/special-topics/emergency-preparedness/notification-enforcement-discretion-telehealth/index.html. Updated March 30, 2020. Accessed May 6, 2020.
3. US Department of Health & Human Services. What is a “non-public facing” remote communication product? https://www.hhs.gov/hipaa/for-professionals/faq/3024/what-is-a-non-public-facing-remote-communication-product/index.html. Updated April 10, 2020. Accessed May 6, 2020.
4. Huben-Kearney A. Risk management amid a global pandemic. Psychiatric News. https://psychnews.psychiatryonline.org/doi/10.1176/appi.pn.2020.5a38. Published April 28, 2020. Accessed May 6, 2020.
5. Centers for Medicare & Medicaid Services. COVID-19 emergency declaration blanket waivers for health care providers. https://www.cms.gov/files/document/summary-covid-19-emergency-declaration-waivers.pdf. Published April 29, 2020. Accessed May 6, 2020.
6. American Psychiatric Association. Update on telehealth restrictions in response to COVID-19. https://www.psychiatry.org/psychiatrists/practice/telepsychiatry/blog/apa-resources-on-telepsychiatry-and-covid-19. Updated May 1, 2020. Accessed May 6, 2020.
7. US Drug Enforcement Agency. How to prescribe controlled substances to patients during the COVID-19 public health emergency. https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-023)(DEA075)Decision_Tree_(Final)_33120_2007.pdf. Published March 31, 2020. Accessed on May 6, 2020.

Article PDF
Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina. He is one of Current Psychiatry’s Department Editors for Pearls.

Disclosure
The author reports no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products. The mention of products in this article does not constitute endorsement by the author.

Issue
Current Psychiatry - 19(6)
Publications
Topics
Page Number
e12-e14
Sections
Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina. He is one of Current Psychiatry’s Department Editors for Pearls.

Disclosure
The author reports no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products. The mention of products in this article does not constitute endorsement by the author.

Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina. He is one of Current Psychiatry’s Department Editors for Pearls.

Disclosure
The author reports no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products. The mention of products in this article does not constitute endorsement by the author.

Article PDF
Article PDF

In addition to affecting our personal lives, coronavirus disease 2019 (COVID-19) has altered the way we practice psychiatry. Telepsychiatry—the delivery of mental health services via remote communication—is being used to replace face-to-face outpatient encounters. Several rules and regulations governing the provision of care and prescribing have been temporarily modified or suspended to allow clinicians to more easily use telepsychiatry to care for their patients. Although these requirements are continually changing, here I review some of the telepsychiatry rules and regulations clinicians need to understand to minimize their risk for liability.

Changes in light of COVID-19

In March 2020, the Centers for Medicare & Medicaid Services (CMS) released guidance that allows Medicare beneficiaries to receive various services at home through telehealth without having to travel to a doctor’s office or hospital.1 Many commercial insurers also are allowing patients to receive telehealth services in their home. The US Department of Health & Human Services Office for Civil Rights, which enforces the Health Insurance Portability and Accountability Act (HIPAA), reported in March 2020 that it will not impose penalties for not complying with HIPAA requirements on clinicians who provide good-faith telepsychiatry during the COVID-19 crisis.2

Clinicians who want to use audio or video remote communication to provide any type of telehealth services (not just those related to COVID-19) should use “non-public facing” products.2 Non-public facing products (eg, Skype, WhatsApp video call, Zoom) allow only the intended parties to participate in the communication.3 Usually, these products employ end-to-end encryption, which allows only those engaging in communication to see and hear what is transmitted.3 To limit access and verify the participants, these products also support individual user accounts, login names, and passwords.3 In addition, these products usually allow participants and/or “the host” to exert some degree of control over particular features, such as choosing to record the communication, mute, or turn off the video or audio signal.3 When using these products, clinicians should enable all available encryption and privacy modes.2

“Public-facing” products (eg, Facebook Live, TikTok, Twitch) should not be used to provide telepsychiatry services because they are designed to be open to the public or allow for wide or indiscriminate access to the communication.2,3 Clinicians who desire additional privacy protections (and a more permanent solution) should choose a HIPAA-compliant telehealth vendor (eg, Doxy.me, VSee, Zoom for Healthcare) and obtain a Business Associate Agreement with the vendor to ensure data protection and security.2,4

Regardless of the product, obtain informed consent from your patients that authorizes the use of remote communication.4 Inform your patients of any potential privacy or security breaches, the need for interactions to be conducted in a location that provides privacy, and whether the specific technology used is HIPAA-compliant.4 Document that your patients understand these issues before using remote communication.4

How licensing requirements have changed

As of March 31, 2020, the CMS temporarily waived the requirement that out-of-state clinicians be licensed in the state where they are providing services to Medicare beneficiaries.5 The CMS waived this requirement for clinicians who meet the following 4 conditions5,6:

  • must be enrolled in Medicare
  • must possess a valid license to practice in the state that relates to his/her Medicare enrollment
  • are furnishing services—whether in person or via telepsychiatry—in a state where the emergency is occurring to contribute to relief efforts in his/her professional capacity
  • are not excluded from practicing in any state that is part of the nationally declared emergency area.

Note that individual state licensure requirements continue to apply unless waived by the state.6 Therefore, in order for clinicians to see Medicare patients via remote communication under the 4 conditions described above, the state also would have to waive its licensure requirements for the type of practice for which the clinicians are licensed in their own state.6 Regarding commercial payers, in general, clinicians providing telepsychiatry services need a license to practice in the state where the patient is located at the time services are provided.6 During the COVID-19 pandemic, many governors issued executive orders waiving licensure requirements, and many have accelerated granting temporary licenses to out-of-state clinicians who wish to provide telepsychiatry services to the residents of their state.4

Continue to: Prescribing via telepsychiatry

 

 

Prescribing via telepsychiatry

Effective March 31, 2020 and lasting for the duration of COVID-19 emergency declaration, the Drug Enforcement Agency (DEA) suspended the Ryan Haight Online Pharmacy Consumer Protection Act of 2008, which requires clinicians to conduct initial, in-person examinations of patients before they can prescribe controlled substances electronically.6,7 The DEA suspension allows clinicians to prescribe controlled substances after conducting an initial evaluation via remote communication. In addition, the DEA waived the requirement that a clinician needs to hold a DEA license in the state where the patient is located to be able to prescribe a controlled substance electronically.4,6 However, you still must comply with all other state laws and regulations for prescribing controlled substances.4

Staying informed

Although several telepsychiatry rules and regulations have been modified or suspended during the COVID-19 pandemic, the standard of care for services rendered via telepsychiatry remains the same as services provided via face-to-face encounters, including patient evaluation and assessment, treatment plans, medication, and documentation.4 Clinicians can keep up-to-date on how practicing telepsychiatry may evolve during these times by using the following resources from the American Psychiatric Association:

In addition to affecting our personal lives, coronavirus disease 2019 (COVID-19) has altered the way we practice psychiatry. Telepsychiatry—the delivery of mental health services via remote communication—is being used to replace face-to-face outpatient encounters. Several rules and regulations governing the provision of care and prescribing have been temporarily modified or suspended to allow clinicians to more easily use telepsychiatry to care for their patients. Although these requirements are continually changing, here I review some of the telepsychiatry rules and regulations clinicians need to understand to minimize their risk for liability.

Changes in light of COVID-19

In March 2020, the Centers for Medicare & Medicaid Services (CMS) released guidance that allows Medicare beneficiaries to receive various services at home through telehealth without having to travel to a doctor’s office or hospital.1 Many commercial insurers also are allowing patients to receive telehealth services in their home. The US Department of Health & Human Services Office for Civil Rights, which enforces the Health Insurance Portability and Accountability Act (HIPAA), reported in March 2020 that it will not impose penalties for not complying with HIPAA requirements on clinicians who provide good-faith telepsychiatry during the COVID-19 crisis.2

Clinicians who want to use audio or video remote communication to provide any type of telehealth services (not just those related to COVID-19) should use “non-public facing” products.2 Non-public facing products (eg, Skype, WhatsApp video call, Zoom) allow only the intended parties to participate in the communication.3 Usually, these products employ end-to-end encryption, which allows only those engaging in communication to see and hear what is transmitted.3 To limit access and verify the participants, these products also support individual user accounts, login names, and passwords.3 In addition, these products usually allow participants and/or “the host” to exert some degree of control over particular features, such as choosing to record the communication, mute, or turn off the video or audio signal.3 When using these products, clinicians should enable all available encryption and privacy modes.2

“Public-facing” products (eg, Facebook Live, TikTok, Twitch) should not be used to provide telepsychiatry services because they are designed to be open to the public or allow for wide or indiscriminate access to the communication.2,3 Clinicians who desire additional privacy protections (and a more permanent solution) should choose a HIPAA-compliant telehealth vendor (eg, Doxy.me, VSee, Zoom for Healthcare) and obtain a Business Associate Agreement with the vendor to ensure data protection and security.2,4

Regardless of the product, obtain informed consent from your patients that authorizes the use of remote communication.4 Inform your patients of any potential privacy or security breaches, the need for interactions to be conducted in a location that provides privacy, and whether the specific technology used is HIPAA-compliant.4 Document that your patients understand these issues before using remote communication.4

How licensing requirements have changed

As of March 31, 2020, the CMS temporarily waived the requirement that out-of-state clinicians be licensed in the state where they are providing services to Medicare beneficiaries.5 The CMS waived this requirement for clinicians who meet the following 4 conditions5,6:

  • must be enrolled in Medicare
  • must possess a valid license to practice in the state that relates to his/her Medicare enrollment
  • are furnishing services—whether in person or via telepsychiatry—in a state where the emergency is occurring to contribute to relief efforts in his/her professional capacity
  • are not excluded from practicing in any state that is part of the nationally declared emergency area.

Note that individual state licensure requirements continue to apply unless waived by the state.6 Therefore, in order for clinicians to see Medicare patients via remote communication under the 4 conditions described above, the state also would have to waive its licensure requirements for the type of practice for which the clinicians are licensed in their own state.6 Regarding commercial payers, in general, clinicians providing telepsychiatry services need a license to practice in the state where the patient is located at the time services are provided.6 During the COVID-19 pandemic, many governors issued executive orders waiving licensure requirements, and many have accelerated granting temporary licenses to out-of-state clinicians who wish to provide telepsychiatry services to the residents of their state.4

Continue to: Prescribing via telepsychiatry

 

 

Prescribing via telepsychiatry

Effective March 31, 2020 and lasting for the duration of COVID-19 emergency declaration, the Drug Enforcement Agency (DEA) suspended the Ryan Haight Online Pharmacy Consumer Protection Act of 2008, which requires clinicians to conduct initial, in-person examinations of patients before they can prescribe controlled substances electronically.6,7 The DEA suspension allows clinicians to prescribe controlled substances after conducting an initial evaluation via remote communication. In addition, the DEA waived the requirement that a clinician needs to hold a DEA license in the state where the patient is located to be able to prescribe a controlled substance electronically.4,6 However, you still must comply with all other state laws and regulations for prescribing controlled substances.4

Staying informed

Although several telepsychiatry rules and regulations have been modified or suspended during the COVID-19 pandemic, the standard of care for services rendered via telepsychiatry remains the same as services provided via face-to-face encounters, including patient evaluation and assessment, treatment plans, medication, and documentation.4 Clinicians can keep up-to-date on how practicing telepsychiatry may evolve during these times by using the following resources from the American Psychiatric Association:

References

1. Centers for Medicare and Medicaid Services. COVID-19: President Trump expands telehealth benefits for Medicare beneficiaries during COVID-19 outbreak. https://www.cms.gov/outreach-and-educationoutreachffsprovpartprogprovider-partnership-email-archive/2020-03-17. Published March 17, 2020. Accessed May 6, 2020.
2. US Department of Health & Human Services. Notification of enforcement discretion for telehealth remote communications during the COVID-19 nationwide public health emergency. https://www.hhs.gov/hipaa/for-professionals/special-topics/emergency-preparedness/notification-enforcement-discretion-telehealth/index.html. Updated March 30, 2020. Accessed May 6, 2020.
3. US Department of Health & Human Services. What is a “non-public facing” remote communication product? https://www.hhs.gov/hipaa/for-professionals/faq/3024/what-is-a-non-public-facing-remote-communication-product/index.html. Updated April 10, 2020. Accessed May 6, 2020.
4. Huben-Kearney A. Risk management amid a global pandemic. Psychiatric News. https://psychnews.psychiatryonline.org/doi/10.1176/appi.pn.2020.5a38. Published April 28, 2020. Accessed May 6, 2020.
5. Centers for Medicare & Medicaid Services. COVID-19 emergency declaration blanket waivers for health care providers. https://www.cms.gov/files/document/summary-covid-19-emergency-declaration-waivers.pdf. Published April 29, 2020. Accessed May 6, 2020.
6. American Psychiatric Association. Update on telehealth restrictions in response to COVID-19. https://www.psychiatry.org/psychiatrists/practice/telepsychiatry/blog/apa-resources-on-telepsychiatry-and-covid-19. Updated May 1, 2020. Accessed May 6, 2020.
7. US Drug Enforcement Agency. How to prescribe controlled substances to patients during the COVID-19 public health emergency. https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-023)(DEA075)Decision_Tree_(Final)_33120_2007.pdf. Published March 31, 2020. Accessed on May 6, 2020.

References

1. Centers for Medicare and Medicaid Services. COVID-19: President Trump expands telehealth benefits for Medicare beneficiaries during COVID-19 outbreak. https://www.cms.gov/outreach-and-educationoutreachffsprovpartprogprovider-partnership-email-archive/2020-03-17. Published March 17, 2020. Accessed May 6, 2020.
2. US Department of Health & Human Services. Notification of enforcement discretion for telehealth remote communications during the COVID-19 nationwide public health emergency. https://www.hhs.gov/hipaa/for-professionals/special-topics/emergency-preparedness/notification-enforcement-discretion-telehealth/index.html. Updated March 30, 2020. Accessed May 6, 2020.
3. US Department of Health & Human Services. What is a “non-public facing” remote communication product? https://www.hhs.gov/hipaa/for-professionals/faq/3024/what-is-a-non-public-facing-remote-communication-product/index.html. Updated April 10, 2020. Accessed May 6, 2020.
4. Huben-Kearney A. Risk management amid a global pandemic. Psychiatric News. https://psychnews.psychiatryonline.org/doi/10.1176/appi.pn.2020.5a38. Published April 28, 2020. Accessed May 6, 2020.
5. Centers for Medicare & Medicaid Services. COVID-19 emergency declaration blanket waivers for health care providers. https://www.cms.gov/files/document/summary-covid-19-emergency-declaration-waivers.pdf. Published April 29, 2020. Accessed May 6, 2020.
6. American Psychiatric Association. Update on telehealth restrictions in response to COVID-19. https://www.psychiatry.org/psychiatrists/practice/telepsychiatry/blog/apa-resources-on-telepsychiatry-and-covid-19. Updated May 1, 2020. Accessed May 6, 2020.
7. US Drug Enforcement Agency. How to prescribe controlled substances to patients during the COVID-19 public health emergency. https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-023)(DEA075)Decision_Tree_(Final)_33120_2007.pdf. Published March 31, 2020. Accessed on May 6, 2020.

Issue
Current Psychiatry - 19(6)
Issue
Current Psychiatry - 19(6)
Page Number
e12-e14
Page Number
e12-e14
Publications
Publications
Topics
Article Type
Display Headline
Telepsychiatry during COVID-19: Understanding the rules
Display Headline
Telepsychiatry during COVID-19: Understanding the rules
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Article PDF Media

Taking care of ourselves during the COVID-19 pandemic

Article Type
Changed
Thu, 08/26/2021 - 16:11
Display Headline
Taking care of ourselves during the COVID-19 pandemic

Since early March 2020, when the World Health Organization (WHO) declared the coronavirus disease 2019 (COVID-19) outbreak a pandemic,1 our lives have been drastically altered. As the number of COVID-19 cases continued to rise, businesses closed, jobs disappeared, store shelves were emptied, sporting events were postponed or cancelled, the economy tanked, and social distancing became a new way of life.

COVID-19 has created uncertainty in our lives, both professionally and personally. This can be difficult to face because we are programmed to desire certainty, to want to know what is happening around us, and to notice threatening people and/or situations.2 Uncertainty can lead us to feel stressed or overwhelmed due to a sense of losing control.2 Our mental and physical well-being can begin to deteriorate. We can feel more frazzled, angry, helpless, sad, frustrated, or confused,2 and we can become more isolated. These thoughts and feelings can make our daily activities more cumbersome.

To maintain our own mental and physical well-being, we must give ourselves permission to change the narrative from “the patient is always first” to “the patient always—but not always first.”3 Doing so will allow us to continue to help our patients.3 Despite the pervasive uncertainty, taking the following actions can help us to maintain our own mental and physical health.2-5

Minimize news that causes us to feel worse. COVID-19 news dominates the headlines. The near-constant, ever-changing stream of reports can cause us to feel overwhelmed and stressed. We should get information only from trusted sources, such as the Centers for Disease Control and Prevention (CDC) and the WHO, and do so only once or twice a day. We should seek out only facts, and not focus on rumors that could worsen our thoughts and feelings.

Social distancing does not mean social isolation. To reduce the spread of COVID-19, social distancing has become necessary, but we should not completely avoid each other. We can still communicate with others via texting, e-mail, social media, video conferences, and phone calls. Despite not being able to engage in socially accepted physical greetings such as handshakes or hugs, we should not hesitate to verbally greet each other, albeit from a distance. In addition, we can still go outside while maintaining a safe distance from each other.

Keep a routine. Because we are creatures of habit, a routine (even a new one) can help sustain our mental and physical well-being. We should continue to:

  • remain active at our usual times
  • get adequate sleep and rest
  • eat nutritious food
  • engage in physical activity
  • maintain contact with our family and friends
  • continue treatments for any physical and/or mental conditions.

Avoid unhealthy coping strategies, such as binge-watching TV shows, because these can worsen psychological and physical well-being. You are likely to know what to do to “de-stress” yourself, and you should not hesitate to keep yourself psychologically and physically fit. Continue to engage in CDC-recommended hygienic practices such as frequently washing your hands with soap and water for at least 20 seconds, avoiding close contact with people who are sick, and staying at home when you are sick. Seek mental health and/or medical treatment as necessary.

Continue to: Put the uncertainty in perspective

 

 

Put the uncertainty in perspective. Hopefully, there will come a time when we will resume our normal lives. Until then, we should acknowledge the uncertainty without immediately reacting to the worries that it creates. It is important to take a step back and think before reacting. This involves challenging ourselves to stay in the present and resist projecting into the future. Use this time for self-care, reflection, and/or catching up on the “to-do list.” We should be kind to ourselves and those around us. As best we can, we should show empathy to others and try to help our friends, families, and colleagues who are having a difficult time managing this crisis.

References

1. Ghebreyesus TA. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed April 8, 2020.
2. Marshall D. Taking care of your mental health in the face of uncertainty. American Foundation for Suicide Prevention. https://afsp.org/taking-care-of-your-mental-health-in-the-face-of-uncertainty/. Published March 10, 2020. Accessed April 8, 2020.
3. Unadkat S, Farquhar M. Doctors’ wellbeing: self-care during the COVID-19 pandemic. BMJ. 2020;368:m1150. doi: 10.1136/bmj.m1150.
4. World Health Organization. Mental health and psychosocial considerations during the COVD-19 outbreak. https://www.who.int/docs/default-source/coronaviruse/mental-health-considerations.pdf. Published March 18, 2020. Accessed April 8, 2020.
5. Brewer K. Coronavirus: how to protect your mental health. https://www.bbc.com/news/health-51873799. Published March 16, 2020. Accessed April 8, 2020.

Article PDF
Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry, and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina.

Disclosure
The author reports no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Issue
Current Psychiatry - 19(5)
Publications
Topics
Page Number
46-47
Sections
Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry, and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina.

Disclosure
The author reports no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry, and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina.

Disclosure
The author reports no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Article PDF
Article PDF

Since early March 2020, when the World Health Organization (WHO) declared the coronavirus disease 2019 (COVID-19) outbreak a pandemic,1 our lives have been drastically altered. As the number of COVID-19 cases continued to rise, businesses closed, jobs disappeared, store shelves were emptied, sporting events were postponed or cancelled, the economy tanked, and social distancing became a new way of life.

COVID-19 has created uncertainty in our lives, both professionally and personally. This can be difficult to face because we are programmed to desire certainty, to want to know what is happening around us, and to notice threatening people and/or situations.2 Uncertainty can lead us to feel stressed or overwhelmed due to a sense of losing control.2 Our mental and physical well-being can begin to deteriorate. We can feel more frazzled, angry, helpless, sad, frustrated, or confused,2 and we can become more isolated. These thoughts and feelings can make our daily activities more cumbersome.

To maintain our own mental and physical well-being, we must give ourselves permission to change the narrative from “the patient is always first” to “the patient always—but not always first.”3 Doing so will allow us to continue to help our patients.3 Despite the pervasive uncertainty, taking the following actions can help us to maintain our own mental and physical health.2-5

Minimize news that causes us to feel worse. COVID-19 news dominates the headlines. The near-constant, ever-changing stream of reports can cause us to feel overwhelmed and stressed. We should get information only from trusted sources, such as the Centers for Disease Control and Prevention (CDC) and the WHO, and do so only once or twice a day. We should seek out only facts, and not focus on rumors that could worsen our thoughts and feelings.

Social distancing does not mean social isolation. To reduce the spread of COVID-19, social distancing has become necessary, but we should not completely avoid each other. We can still communicate with others via texting, e-mail, social media, video conferences, and phone calls. Despite not being able to engage in socially accepted physical greetings such as handshakes or hugs, we should not hesitate to verbally greet each other, albeit from a distance. In addition, we can still go outside while maintaining a safe distance from each other.

Keep a routine. Because we are creatures of habit, a routine (even a new one) can help sustain our mental and physical well-being. We should continue to:

  • remain active at our usual times
  • get adequate sleep and rest
  • eat nutritious food
  • engage in physical activity
  • maintain contact with our family and friends
  • continue treatments for any physical and/or mental conditions.

Avoid unhealthy coping strategies, such as binge-watching TV shows, because these can worsen psychological and physical well-being. You are likely to know what to do to “de-stress” yourself, and you should not hesitate to keep yourself psychologically and physically fit. Continue to engage in CDC-recommended hygienic practices such as frequently washing your hands with soap and water for at least 20 seconds, avoiding close contact with people who are sick, and staying at home when you are sick. Seek mental health and/or medical treatment as necessary.

Continue to: Put the uncertainty in perspective

 

 

Put the uncertainty in perspective. Hopefully, there will come a time when we will resume our normal lives. Until then, we should acknowledge the uncertainty without immediately reacting to the worries that it creates. It is important to take a step back and think before reacting. This involves challenging ourselves to stay in the present and resist projecting into the future. Use this time for self-care, reflection, and/or catching up on the “to-do list.” We should be kind to ourselves and those around us. As best we can, we should show empathy to others and try to help our friends, families, and colleagues who are having a difficult time managing this crisis.

Since early March 2020, when the World Health Organization (WHO) declared the coronavirus disease 2019 (COVID-19) outbreak a pandemic,1 our lives have been drastically altered. As the number of COVID-19 cases continued to rise, businesses closed, jobs disappeared, store shelves were emptied, sporting events were postponed or cancelled, the economy tanked, and social distancing became a new way of life.

COVID-19 has created uncertainty in our lives, both professionally and personally. This can be difficult to face because we are programmed to desire certainty, to want to know what is happening around us, and to notice threatening people and/or situations.2 Uncertainty can lead us to feel stressed or overwhelmed due to a sense of losing control.2 Our mental and physical well-being can begin to deteriorate. We can feel more frazzled, angry, helpless, sad, frustrated, or confused,2 and we can become more isolated. These thoughts and feelings can make our daily activities more cumbersome.

To maintain our own mental and physical well-being, we must give ourselves permission to change the narrative from “the patient is always first” to “the patient always—but not always first.”3 Doing so will allow us to continue to help our patients.3 Despite the pervasive uncertainty, taking the following actions can help us to maintain our own mental and physical health.2-5

Minimize news that causes us to feel worse. COVID-19 news dominates the headlines. The near-constant, ever-changing stream of reports can cause us to feel overwhelmed and stressed. We should get information only from trusted sources, such as the Centers for Disease Control and Prevention (CDC) and the WHO, and do so only once or twice a day. We should seek out only facts, and not focus on rumors that could worsen our thoughts and feelings.

Social distancing does not mean social isolation. To reduce the spread of COVID-19, social distancing has become necessary, but we should not completely avoid each other. We can still communicate with others via texting, e-mail, social media, video conferences, and phone calls. Despite not being able to engage in socially accepted physical greetings such as handshakes or hugs, we should not hesitate to verbally greet each other, albeit from a distance. In addition, we can still go outside while maintaining a safe distance from each other.

Keep a routine. Because we are creatures of habit, a routine (even a new one) can help sustain our mental and physical well-being. We should continue to:

  • remain active at our usual times
  • get adequate sleep and rest
  • eat nutritious food
  • engage in physical activity
  • maintain contact with our family and friends
  • continue treatments for any physical and/or mental conditions.

Avoid unhealthy coping strategies, such as binge-watching TV shows, because these can worsen psychological and physical well-being. You are likely to know what to do to “de-stress” yourself, and you should not hesitate to keep yourself psychologically and physically fit. Continue to engage in CDC-recommended hygienic practices such as frequently washing your hands with soap and water for at least 20 seconds, avoiding close contact with people who are sick, and staying at home when you are sick. Seek mental health and/or medical treatment as necessary.

Continue to: Put the uncertainty in perspective

 

 

Put the uncertainty in perspective. Hopefully, there will come a time when we will resume our normal lives. Until then, we should acknowledge the uncertainty without immediately reacting to the worries that it creates. It is important to take a step back and think before reacting. This involves challenging ourselves to stay in the present and resist projecting into the future. Use this time for self-care, reflection, and/or catching up on the “to-do list.” We should be kind to ourselves and those around us. As best we can, we should show empathy to others and try to help our friends, families, and colleagues who are having a difficult time managing this crisis.

References

1. Ghebreyesus TA. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed April 8, 2020.
2. Marshall D. Taking care of your mental health in the face of uncertainty. American Foundation for Suicide Prevention. https://afsp.org/taking-care-of-your-mental-health-in-the-face-of-uncertainty/. Published March 10, 2020. Accessed April 8, 2020.
3. Unadkat S, Farquhar M. Doctors’ wellbeing: self-care during the COVID-19 pandemic. BMJ. 2020;368:m1150. doi: 10.1136/bmj.m1150.
4. World Health Organization. Mental health and psychosocial considerations during the COVD-19 outbreak. https://www.who.int/docs/default-source/coronaviruse/mental-health-considerations.pdf. Published March 18, 2020. Accessed April 8, 2020.
5. Brewer K. Coronavirus: how to protect your mental health. https://www.bbc.com/news/health-51873799. Published March 16, 2020. Accessed April 8, 2020.

References

1. Ghebreyesus TA. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed April 8, 2020.
2. Marshall D. Taking care of your mental health in the face of uncertainty. American Foundation for Suicide Prevention. https://afsp.org/taking-care-of-your-mental-health-in-the-face-of-uncertainty/. Published March 10, 2020. Accessed April 8, 2020.
3. Unadkat S, Farquhar M. Doctors’ wellbeing: self-care during the COVID-19 pandemic. BMJ. 2020;368:m1150. doi: 10.1136/bmj.m1150.
4. World Health Organization. Mental health and psychosocial considerations during the COVD-19 outbreak. https://www.who.int/docs/default-source/coronaviruse/mental-health-considerations.pdf. Published March 18, 2020. Accessed April 8, 2020.
5. Brewer K. Coronavirus: how to protect your mental health. https://www.bbc.com/news/health-51873799. Published March 16, 2020. Accessed April 8, 2020.

Issue
Current Psychiatry - 19(5)
Issue
Current Psychiatry - 19(5)
Page Number
46-47
Page Number
46-47
Publications
Publications
Topics
Article Type
Display Headline
Taking care of ourselves during the COVID-19 pandemic
Display Headline
Taking care of ourselves during the COVID-19 pandemic
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Strategies for treating patients with health anxiety

Article Type
Changed
Thu, 08/26/2021 - 16:18
Display Headline
Strategies for treating patients with health anxiety

Up to 20% of patients in medical settings experience health anxiety.1,2 In DSM-IV-TR, this condition was called hypochondriasis, and its core feature was having a preoccupation with fears or the idea that one has a serious disease based on a misinterpretation of ≥1 bodily signs or symptoms despite undergoing appropriate medical evaluation.3 In DSM-5, hypochondriasis was removed, and somatic symptom disorder and illness anxiety disorder were introduced.1 Approximately 75% of patients with a previous diagnosis of hypochondriasis meet the diagnostic criteria for somatic symptom disorder, and approximately 25% meet the criteria for illness anxiety disorder.1 In clinical practice, the less pejorative and more commonly used term for these conditions is “health anxiety.”

Patients with health anxiety can be challenging to treat because they persist in believing they have an illness despite appropriate medical evaluation. Clinicians’ responses to such patients can range from feeling the need to do more to alleviate their suffering to strongly disliking them. Although these patients can elicit negative countertransference, we should remember that their lives are being adversely affected due to the substantial functional impairment they experience from their health worries. As psychiatrists, we can help our patients with health anxiety by employing the following strategies.

Maintain constant communication with other clinicians who manage the patient’s medical complaints. A clear line of communication with other clinicians can help minimize inconsistent or conflicting messages and potentially reduce splitting. This also can allow other clinicians to air their concerns, and for you to emphasize to them that patients with health anxiety can have an actual medical disease.

Allow patients to discuss their symptoms without interrupting them. This will help them understand that you are listening to them and taking their worries seriously.2 Elicit further discussion by asking them about2:

  • their perception of their health
  • how frequently they worry about their health
  • fears about what could happen
  • triggers for their worries
  • how seriously they feel other clinicians regard their concerns
  • behaviors they use to subdue their worries
  • avoidance behaviors
  • the impact their worries have on their lives.

Assess patients for the presence of comorbid mental health conditions such as anxiety disorders, mood disorders, psychotic disorders, personality disorders, and substance use disorders. Treating these conditions can help reduce your patients’ health anxiety–related distress and impairment.

Acknowledge that your patients’ symptoms are real to them and genuinely experienced.2 By focusing on worry as the most important symptom and recognizing how discomforting and serious that worry can be, you can validate your patients’ feelings and increase their motivation for continuing treatment.2

Avoid reassuring patients that they are medically healthy, because any relief your patients gain from this can quickly fade, and their anxiety may worsen.2 Instead, acknowledge their concerns by saying, “It’s clear that you are worried about your health. We have ways of helping this, and this will not affect any other treatment you are receiving.”2 This could allow your patients to recognize that they have health anxiety without believing that their medical problems will be disregarded or dismissed.2

Explain to patients that their perceptions could be symptoms of anxiety instead of an actual medical illness, equating health anxiety to a false alarm.2 Ask patients to summarize any information you present to them, because misinterpreting health information is a core feature of health anxiety.2

References

1. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
2. Hedman-Lagerlöf E, Tyrer P, Hague J, et al. Health anxiety. BMJ. 2019;364:I774. doi: 10.1136/bmj.I774.
3. Diagnostic and statistical manual of mental disorders. 4th ed, text rev. Washington, DC: American Psychiatric Association; 2000.

Article PDF
Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina.

Disclosure
The author reports no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Issue
Current Psychiatry - 19(4)
Publications
Topics
Page Number
54-55
Sections
Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina.

Disclosure
The author reports no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina.

Disclosure
The author reports no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Article PDF
Article PDF

Up to 20% of patients in medical settings experience health anxiety.1,2 In DSM-IV-TR, this condition was called hypochondriasis, and its core feature was having a preoccupation with fears or the idea that one has a serious disease based on a misinterpretation of ≥1 bodily signs or symptoms despite undergoing appropriate medical evaluation.3 In DSM-5, hypochondriasis was removed, and somatic symptom disorder and illness anxiety disorder were introduced.1 Approximately 75% of patients with a previous diagnosis of hypochondriasis meet the diagnostic criteria for somatic symptom disorder, and approximately 25% meet the criteria for illness anxiety disorder.1 In clinical practice, the less pejorative and more commonly used term for these conditions is “health anxiety.”

Patients with health anxiety can be challenging to treat because they persist in believing they have an illness despite appropriate medical evaluation. Clinicians’ responses to such patients can range from feeling the need to do more to alleviate their suffering to strongly disliking them. Although these patients can elicit negative countertransference, we should remember that their lives are being adversely affected due to the substantial functional impairment they experience from their health worries. As psychiatrists, we can help our patients with health anxiety by employing the following strategies.

Maintain constant communication with other clinicians who manage the patient’s medical complaints. A clear line of communication with other clinicians can help minimize inconsistent or conflicting messages and potentially reduce splitting. This also can allow other clinicians to air their concerns, and for you to emphasize to them that patients with health anxiety can have an actual medical disease.

Allow patients to discuss their symptoms without interrupting them. This will help them understand that you are listening to them and taking their worries seriously.2 Elicit further discussion by asking them about2:

  • their perception of their health
  • how frequently they worry about their health
  • fears about what could happen
  • triggers for their worries
  • how seriously they feel other clinicians regard their concerns
  • behaviors they use to subdue their worries
  • avoidance behaviors
  • the impact their worries have on their lives.

Assess patients for the presence of comorbid mental health conditions such as anxiety disorders, mood disorders, psychotic disorders, personality disorders, and substance use disorders. Treating these conditions can help reduce your patients’ health anxiety–related distress and impairment.

Acknowledge that your patients’ symptoms are real to them and genuinely experienced.2 By focusing on worry as the most important symptom and recognizing how discomforting and serious that worry can be, you can validate your patients’ feelings and increase their motivation for continuing treatment.2

Avoid reassuring patients that they are medically healthy, because any relief your patients gain from this can quickly fade, and their anxiety may worsen.2 Instead, acknowledge their concerns by saying, “It’s clear that you are worried about your health. We have ways of helping this, and this will not affect any other treatment you are receiving.”2 This could allow your patients to recognize that they have health anxiety without believing that their medical problems will be disregarded or dismissed.2

Explain to patients that their perceptions could be symptoms of anxiety instead of an actual medical illness, equating health anxiety to a false alarm.2 Ask patients to summarize any information you present to them, because misinterpreting health information is a core feature of health anxiety.2

Up to 20% of patients in medical settings experience health anxiety.1,2 In DSM-IV-TR, this condition was called hypochondriasis, and its core feature was having a preoccupation with fears or the idea that one has a serious disease based on a misinterpretation of ≥1 bodily signs or symptoms despite undergoing appropriate medical evaluation.3 In DSM-5, hypochondriasis was removed, and somatic symptom disorder and illness anxiety disorder were introduced.1 Approximately 75% of patients with a previous diagnosis of hypochondriasis meet the diagnostic criteria for somatic symptom disorder, and approximately 25% meet the criteria for illness anxiety disorder.1 In clinical practice, the less pejorative and more commonly used term for these conditions is “health anxiety.”

Patients with health anxiety can be challenging to treat because they persist in believing they have an illness despite appropriate medical evaluation. Clinicians’ responses to such patients can range from feeling the need to do more to alleviate their suffering to strongly disliking them. Although these patients can elicit negative countertransference, we should remember that their lives are being adversely affected due to the substantial functional impairment they experience from their health worries. As psychiatrists, we can help our patients with health anxiety by employing the following strategies.

Maintain constant communication with other clinicians who manage the patient’s medical complaints. A clear line of communication with other clinicians can help minimize inconsistent or conflicting messages and potentially reduce splitting. This also can allow other clinicians to air their concerns, and for you to emphasize to them that patients with health anxiety can have an actual medical disease.

Allow patients to discuss their symptoms without interrupting them. This will help them understand that you are listening to them and taking their worries seriously.2 Elicit further discussion by asking them about2:

  • their perception of their health
  • how frequently they worry about their health
  • fears about what could happen
  • triggers for their worries
  • how seriously they feel other clinicians regard their concerns
  • behaviors they use to subdue their worries
  • avoidance behaviors
  • the impact their worries have on their lives.

Assess patients for the presence of comorbid mental health conditions such as anxiety disorders, mood disorders, psychotic disorders, personality disorders, and substance use disorders. Treating these conditions can help reduce your patients’ health anxiety–related distress and impairment.

Acknowledge that your patients’ symptoms are real to them and genuinely experienced.2 By focusing on worry as the most important symptom and recognizing how discomforting and serious that worry can be, you can validate your patients’ feelings and increase their motivation for continuing treatment.2

Avoid reassuring patients that they are medically healthy, because any relief your patients gain from this can quickly fade, and their anxiety may worsen.2 Instead, acknowledge their concerns by saying, “It’s clear that you are worried about your health. We have ways of helping this, and this will not affect any other treatment you are receiving.”2 This could allow your patients to recognize that they have health anxiety without believing that their medical problems will be disregarded or dismissed.2

Explain to patients that their perceptions could be symptoms of anxiety instead of an actual medical illness, equating health anxiety to a false alarm.2 Ask patients to summarize any information you present to them, because misinterpreting health information is a core feature of health anxiety.2

References

1. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
2. Hedman-Lagerlöf E, Tyrer P, Hague J, et al. Health anxiety. BMJ. 2019;364:I774. doi: 10.1136/bmj.I774.
3. Diagnostic and statistical manual of mental disorders. 4th ed, text rev. Washington, DC: American Psychiatric Association; 2000.

References

1. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
2. Hedman-Lagerlöf E, Tyrer P, Hague J, et al. Health anxiety. BMJ. 2019;364:I774. doi: 10.1136/bmj.I774.
3. Diagnostic and statistical manual of mental disorders. 4th ed, text rev. Washington, DC: American Psychiatric Association; 2000.

Issue
Current Psychiatry - 19(4)
Issue
Current Psychiatry - 19(4)
Page Number
54-55
Page Number
54-55
Publications
Publications
Topics
Article Type
Display Headline
Strategies for treating patients with health anxiety
Display Headline
Strategies for treating patients with health anxiety
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Interacting with colleagues on social media: Tips for avoiding trouble

Article Type
Changed
Mon, 03/02/2020 - 10:47
Display Headline
Interacting with colleagues on social media: Tips for avoiding trouble

As clinicians, we increasingly communicate with each other via social media platforms to network, collaborate on research, find professional and personal support, refer patients, or hold academic conversations.1,2 Although it is convenient, this form of online communication directly and indirectly breaks down barriers between our professional and personal lives, which can make it challenging to avoid behavior that could negatively affect one’s professional image.2

Although some medical organizations have offered guidelines on health care professionals’ use of social media,2,3 these are subjective and not evidence-based. Here I offer some suggestions for appropriately interacting with your colleagues (ie, individuals who are not your personal friends) on social media.

Think before you post. Consider the potential professional ramifications of what you are about to post, and don’t post anything that may have adverse consequences on your image or that of psychiatry as a whole.

Don’t post derogatory or defamatory statements about colleagues. Such actions may violate professional codes of conduct. Disagreeing with colleagues on social media is common, but your posts should be respectful, friendly, and reflect positively on the profession.2 Avoid making negative statements—even in jest—about your colleagues’ skills or professional experience, because such communication is not appropriate for public dissemination.2

If you notice colleagues posting unprofessional content that could negatively affect their careers or the public’s trust in psychiatry, tactfully express your concerns to them, and suggest that they take appropriate measures to rectify the situation.2 Be aware of your state’s laws and regulations about mandated reporting if you discover a colleague’s online content violates the scope of clinical practice or ethical standards.1 If the content is in violation of the law or medical board regulations, you may have a legal obligation to report that colleague to law enforcement, the licensing board, and/or his/her employer.1,2

Avoid online snooping into the personal lives of colleagues. Respect their privacy when viewing their posts about personal activities that are not germane to their professional services.1 If you find videos, images, or messages that reveal private, confidential, or sensitive information about a colleague, do not distribute that information without the colleague’s consent.1

Be careful when accepting friend requests. Conflicts could arise if you accept friend requests from some but not all of your colleagues; this could be interpreted as favoritism and potentially create problematic work relationships.2 Be consistent in accepting or rejecting colleagues’ friend requests. Consider using an employment-oriented social media platform to connect with colleagues outside of the workplace.2

References

1. Reamer FG. Evolving standards of care in the age of cybertechnology. Behav Sci Law. 2018;36(2):257-269.
2. Logghe HJ, Boeck MA, Gusani NJ, et al. Best practices for surgeons’ social media use: statement of the Resident and Associate Society of the American College of Surgeons. J Am Coll Surg. 2018;226(3):317-327.
3. Ventola CL. Social media and health care professionals: benefits, risks, and best practices. P T. 2014;39(7):491-499,520.

Article PDF
Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry, and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina.

Disclosure
The author reports no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Issue
Current Psychiatry - 19(3)
Publications
Page Number
51
Sections
Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry, and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina.

Disclosure
The author reports no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry, and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina.

Disclosure
The author reports no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Article PDF
Article PDF

As clinicians, we increasingly communicate with each other via social media platforms to network, collaborate on research, find professional and personal support, refer patients, or hold academic conversations.1,2 Although it is convenient, this form of online communication directly and indirectly breaks down barriers between our professional and personal lives, which can make it challenging to avoid behavior that could negatively affect one’s professional image.2

Although some medical organizations have offered guidelines on health care professionals’ use of social media,2,3 these are subjective and not evidence-based. Here I offer some suggestions for appropriately interacting with your colleagues (ie, individuals who are not your personal friends) on social media.

Think before you post. Consider the potential professional ramifications of what you are about to post, and don’t post anything that may have adverse consequences on your image or that of psychiatry as a whole.

Don’t post derogatory or defamatory statements about colleagues. Such actions may violate professional codes of conduct. Disagreeing with colleagues on social media is common, but your posts should be respectful, friendly, and reflect positively on the profession.2 Avoid making negative statements—even in jest—about your colleagues’ skills or professional experience, because such communication is not appropriate for public dissemination.2

If you notice colleagues posting unprofessional content that could negatively affect their careers or the public’s trust in psychiatry, tactfully express your concerns to them, and suggest that they take appropriate measures to rectify the situation.2 Be aware of your state’s laws and regulations about mandated reporting if you discover a colleague’s online content violates the scope of clinical practice or ethical standards.1 If the content is in violation of the law or medical board regulations, you may have a legal obligation to report that colleague to law enforcement, the licensing board, and/or his/her employer.1,2

Avoid online snooping into the personal lives of colleagues. Respect their privacy when viewing their posts about personal activities that are not germane to their professional services.1 If you find videos, images, or messages that reveal private, confidential, or sensitive information about a colleague, do not distribute that information without the colleague’s consent.1

Be careful when accepting friend requests. Conflicts could arise if you accept friend requests from some but not all of your colleagues; this could be interpreted as favoritism and potentially create problematic work relationships.2 Be consistent in accepting or rejecting colleagues’ friend requests. Consider using an employment-oriented social media platform to connect with colleagues outside of the workplace.2

As clinicians, we increasingly communicate with each other via social media platforms to network, collaborate on research, find professional and personal support, refer patients, or hold academic conversations.1,2 Although it is convenient, this form of online communication directly and indirectly breaks down barriers between our professional and personal lives, which can make it challenging to avoid behavior that could negatively affect one’s professional image.2

Although some medical organizations have offered guidelines on health care professionals’ use of social media,2,3 these are subjective and not evidence-based. Here I offer some suggestions for appropriately interacting with your colleagues (ie, individuals who are not your personal friends) on social media.

Think before you post. Consider the potential professional ramifications of what you are about to post, and don’t post anything that may have adverse consequences on your image or that of psychiatry as a whole.

Don’t post derogatory or defamatory statements about colleagues. Such actions may violate professional codes of conduct. Disagreeing with colleagues on social media is common, but your posts should be respectful, friendly, and reflect positively on the profession.2 Avoid making negative statements—even in jest—about your colleagues’ skills or professional experience, because such communication is not appropriate for public dissemination.2

If you notice colleagues posting unprofessional content that could negatively affect their careers or the public’s trust in psychiatry, tactfully express your concerns to them, and suggest that they take appropriate measures to rectify the situation.2 Be aware of your state’s laws and regulations about mandated reporting if you discover a colleague’s online content violates the scope of clinical practice or ethical standards.1 If the content is in violation of the law or medical board regulations, you may have a legal obligation to report that colleague to law enforcement, the licensing board, and/or his/her employer.1,2

Avoid online snooping into the personal lives of colleagues. Respect their privacy when viewing their posts about personal activities that are not germane to their professional services.1 If you find videos, images, or messages that reveal private, confidential, or sensitive information about a colleague, do not distribute that information without the colleague’s consent.1

Be careful when accepting friend requests. Conflicts could arise if you accept friend requests from some but not all of your colleagues; this could be interpreted as favoritism and potentially create problematic work relationships.2 Be consistent in accepting or rejecting colleagues’ friend requests. Consider using an employment-oriented social media platform to connect with colleagues outside of the workplace.2

References

1. Reamer FG. Evolving standards of care in the age of cybertechnology. Behav Sci Law. 2018;36(2):257-269.
2. Logghe HJ, Boeck MA, Gusani NJ, et al. Best practices for surgeons’ social media use: statement of the Resident and Associate Society of the American College of Surgeons. J Am Coll Surg. 2018;226(3):317-327.
3. Ventola CL. Social media and health care professionals: benefits, risks, and best practices. P T. 2014;39(7):491-499,520.

References

1. Reamer FG. Evolving standards of care in the age of cybertechnology. Behav Sci Law. 2018;36(2):257-269.
2. Logghe HJ, Boeck MA, Gusani NJ, et al. Best practices for surgeons’ social media use: statement of the Resident and Associate Society of the American College of Surgeons. J Am Coll Surg. 2018;226(3):317-327.
3. Ventola CL. Social media and health care professionals: benefits, risks, and best practices. P T. 2014;39(7):491-499,520.

Issue
Current Psychiatry - 19(3)
Issue
Current Psychiatry - 19(3)
Page Number
51
Page Number
51
Publications
Publications
Article Type
Display Headline
Interacting with colleagues on social media: Tips for avoiding trouble
Display Headline
Interacting with colleagues on social media: Tips for avoiding trouble
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Called to court? Tips for testifying

Article Type
Changed
Fri, 01/03/2020 - 12:50
Display Headline
Called to court? Tips for testifying

As a psychiatrist, you could be called to court to testify as a fact witness in a hearing or trial. Your role as a fact witness would differ from that of an expert witness in that you would likely testify about the information that you have gathered through direct observation of patients or others. Fact witnesses are generally not asked to give expert opinions regarding forensic issues, and treating psychiatrists should not do so about their patients. As a fact witness, depending on the form of litigation, you might be in one of the following 4 roles1:

  • Observer. As the term implies, you have observed an event. For example, you are asked to testify about a fight that you witnessed between another clinician’s patient and a nurse while you were making your rounds on an inpatient unit.
  • Non-defendant treater. You are the treating psychiatrist for a patient who is involved in litigation to recover damages for injuries sustained from a third party. For example, you are asked to testify about your patient’s premorbid functioning before a claimed injury that spurred the lawsuit.
  • Plaintiff. You are suing someone else and may be claiming your own damages. For example, in your attempt to claim damages as a plaintiff, you use your clinical knowledge to testify about your own mental health symptoms and the adverse impact these have had on you.
  • Defendant treater. You are being sued by one of your patients. For example, a patient brings a malpractice case against you for allegations of not meeting the standard of care. You testify about your direct observations of the patient, the diagnoses you provided, and your rationale for the implemented treatment plan.

Preparing yourself as a fact witness

For many psychiatrists, testifying can be an intimidating process. Although there are similarities between testifying in a courtroom and giving a deposition, there are also significant differences. For guidelines on providing depositions, see Knoll and Resnick’s “Deposition dos and don’ts: How to answer 8 tricky questions” (Current Psychiatry. March 2008, p. 25-28,36,39-40).2 Although not an exhaustive list, we offer the following practical tips for testifying as a fact witness.

Don’t panic. Although your first reaction may be to panic upon receiving a subpoena or court order, you should “keep your cool” and remember that the observations you made or treatment provided have already taken place.1 Your role as a fact witness is to inform the judge and jury about what you saw and did.1

Continue to: Refresh your memory and practice

 

 

Refresh your memory and practice. Gather all required information (eg, medical records, your notes, etc.) and review it before testifying. This will help you to recall the facts more accurately when you are asked a question. Consider practicing your testimony with the attorney who requested you to get feedback on how you present yourself.1 However, do not try to memorize what you are going to say because this could make your testimony sound rehearsed and unconvincing.

Plan ahead, and have a pretrial conference. Because court proceedings are unpredictable, you should clear your schedule to allow enough time to appear in court. Before your court appearance, meet with the attorney who requested you to discuss any new facts or issues as well as learn what the attorney aims to accomplish with your testimony.1

Speak clearly in your own words, and avoid jargon. Courtroom officials are unlikely to understand psychiatric jargon. Therefore, you should explain psychiatric terms in language that laypeople would comprehend. Because the court stenographer will require you to use actual words for the court transcripts, you should answer clearly and verbally or respond with a definitive “yes” or “no” (and not by nodding or shaking your head).

Testimony is also not a time for guessing. If you don’t know the answer, you should say “I don’t know.”

References

1. Gutheil TG. The psychiatrist in court: a survival guide. Washington, DC: American Psychiatric Press, Inc.; 1998.
2. Knoll JL, Resnick PJ. Deposition dos and don’ts: how to answer 8 tricky questions. Current Psychiatry. 2008;7(3):25-28,36,39-40.

Article PDF
Author and Disclosure Information

Dr. Frierson is the Alexander G. Donald Professor of Clinical Psychiatry, Vice Chair for Education, and Director of Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina. Dr. Joshi is Associate Professor of Clinical Psychiatry, and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina.

Disclosures
The authors report no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Issue
Current Psychiatry - 19(1)
Publications
Page Number
50-51
Sections
Author and Disclosure Information

Dr. Frierson is the Alexander G. Donald Professor of Clinical Psychiatry, Vice Chair for Education, and Director of Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina. Dr. Joshi is Associate Professor of Clinical Psychiatry, and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina.

Disclosures
The authors report no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Author and Disclosure Information

Dr. Frierson is the Alexander G. Donald Professor of Clinical Psychiatry, Vice Chair for Education, and Director of Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina. Dr. Joshi is Associate Professor of Clinical Psychiatry, and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina.

Disclosures
The authors report no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Article PDF
Article PDF

As a psychiatrist, you could be called to court to testify as a fact witness in a hearing or trial. Your role as a fact witness would differ from that of an expert witness in that you would likely testify about the information that you have gathered through direct observation of patients or others. Fact witnesses are generally not asked to give expert opinions regarding forensic issues, and treating psychiatrists should not do so about their patients. As a fact witness, depending on the form of litigation, you might be in one of the following 4 roles1:

  • Observer. As the term implies, you have observed an event. For example, you are asked to testify about a fight that you witnessed between another clinician’s patient and a nurse while you were making your rounds on an inpatient unit.
  • Non-defendant treater. You are the treating psychiatrist for a patient who is involved in litigation to recover damages for injuries sustained from a third party. For example, you are asked to testify about your patient’s premorbid functioning before a claimed injury that spurred the lawsuit.
  • Plaintiff. You are suing someone else and may be claiming your own damages. For example, in your attempt to claim damages as a plaintiff, you use your clinical knowledge to testify about your own mental health symptoms and the adverse impact these have had on you.
  • Defendant treater. You are being sued by one of your patients. For example, a patient brings a malpractice case against you for allegations of not meeting the standard of care. You testify about your direct observations of the patient, the diagnoses you provided, and your rationale for the implemented treatment plan.

Preparing yourself as a fact witness

For many psychiatrists, testifying can be an intimidating process. Although there are similarities between testifying in a courtroom and giving a deposition, there are also significant differences. For guidelines on providing depositions, see Knoll and Resnick’s “Deposition dos and don’ts: How to answer 8 tricky questions” (Current Psychiatry. March 2008, p. 25-28,36,39-40).2 Although not an exhaustive list, we offer the following practical tips for testifying as a fact witness.

Don’t panic. Although your first reaction may be to panic upon receiving a subpoena or court order, you should “keep your cool” and remember that the observations you made or treatment provided have already taken place.1 Your role as a fact witness is to inform the judge and jury about what you saw and did.1

Continue to: Refresh your memory and practice

 

 

Refresh your memory and practice. Gather all required information (eg, medical records, your notes, etc.) and review it before testifying. This will help you to recall the facts more accurately when you are asked a question. Consider practicing your testimony with the attorney who requested you to get feedback on how you present yourself.1 However, do not try to memorize what you are going to say because this could make your testimony sound rehearsed and unconvincing.

Plan ahead, and have a pretrial conference. Because court proceedings are unpredictable, you should clear your schedule to allow enough time to appear in court. Before your court appearance, meet with the attorney who requested you to discuss any new facts or issues as well as learn what the attorney aims to accomplish with your testimony.1

Speak clearly in your own words, and avoid jargon. Courtroom officials are unlikely to understand psychiatric jargon. Therefore, you should explain psychiatric terms in language that laypeople would comprehend. Because the court stenographer will require you to use actual words for the court transcripts, you should answer clearly and verbally or respond with a definitive “yes” or “no” (and not by nodding or shaking your head).

Testimony is also not a time for guessing. If you don’t know the answer, you should say “I don’t know.”

As a psychiatrist, you could be called to court to testify as a fact witness in a hearing or trial. Your role as a fact witness would differ from that of an expert witness in that you would likely testify about the information that you have gathered through direct observation of patients or others. Fact witnesses are generally not asked to give expert opinions regarding forensic issues, and treating psychiatrists should not do so about their patients. As a fact witness, depending on the form of litigation, you might be in one of the following 4 roles1:

  • Observer. As the term implies, you have observed an event. For example, you are asked to testify about a fight that you witnessed between another clinician’s patient and a nurse while you were making your rounds on an inpatient unit.
  • Non-defendant treater. You are the treating psychiatrist for a patient who is involved in litigation to recover damages for injuries sustained from a third party. For example, you are asked to testify about your patient’s premorbid functioning before a claimed injury that spurred the lawsuit.
  • Plaintiff. You are suing someone else and may be claiming your own damages. For example, in your attempt to claim damages as a plaintiff, you use your clinical knowledge to testify about your own mental health symptoms and the adverse impact these have had on you.
  • Defendant treater. You are being sued by one of your patients. For example, a patient brings a malpractice case against you for allegations of not meeting the standard of care. You testify about your direct observations of the patient, the diagnoses you provided, and your rationale for the implemented treatment plan.

Preparing yourself as a fact witness

For many psychiatrists, testifying can be an intimidating process. Although there are similarities between testifying in a courtroom and giving a deposition, there are also significant differences. For guidelines on providing depositions, see Knoll and Resnick’s “Deposition dos and don’ts: How to answer 8 tricky questions” (Current Psychiatry. March 2008, p. 25-28,36,39-40).2 Although not an exhaustive list, we offer the following practical tips for testifying as a fact witness.

Don’t panic. Although your first reaction may be to panic upon receiving a subpoena or court order, you should “keep your cool” and remember that the observations you made or treatment provided have already taken place.1 Your role as a fact witness is to inform the judge and jury about what you saw and did.1

Continue to: Refresh your memory and practice

 

 

Refresh your memory and practice. Gather all required information (eg, medical records, your notes, etc.) and review it before testifying. This will help you to recall the facts more accurately when you are asked a question. Consider practicing your testimony with the attorney who requested you to get feedback on how you present yourself.1 However, do not try to memorize what you are going to say because this could make your testimony sound rehearsed and unconvincing.

Plan ahead, and have a pretrial conference. Because court proceedings are unpredictable, you should clear your schedule to allow enough time to appear in court. Before your court appearance, meet with the attorney who requested you to discuss any new facts or issues as well as learn what the attorney aims to accomplish with your testimony.1

Speak clearly in your own words, and avoid jargon. Courtroom officials are unlikely to understand psychiatric jargon. Therefore, you should explain psychiatric terms in language that laypeople would comprehend. Because the court stenographer will require you to use actual words for the court transcripts, you should answer clearly and verbally or respond with a definitive “yes” or “no” (and not by nodding or shaking your head).

Testimony is also not a time for guessing. If you don’t know the answer, you should say “I don’t know.”

References

1. Gutheil TG. The psychiatrist in court: a survival guide. Washington, DC: American Psychiatric Press, Inc.; 1998.
2. Knoll JL, Resnick PJ. Deposition dos and don’ts: how to answer 8 tricky questions. Current Psychiatry. 2008;7(3):25-28,36,39-40.

References

1. Gutheil TG. The psychiatrist in court: a survival guide. Washington, DC: American Psychiatric Press, Inc.; 1998.
2. Knoll JL, Resnick PJ. Deposition dos and don’ts: how to answer 8 tricky questions. Current Psychiatry. 2008;7(3):25-28,36,39-40.

Issue
Current Psychiatry - 19(1)
Issue
Current Psychiatry - 19(1)
Page Number
50-51
Page Number
50-51
Publications
Publications
Article Type
Display Headline
Called to court? Tips for testifying
Display Headline
Called to court? Tips for testifying
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

In-flight psychiatric emergencies: What you should know

Article Type
Changed
Mon, 12/02/2019 - 08:49
Display Headline
In-flight psychiatric emergencies: What you should know

Although they are rare, in-flight psychiatric emergencies occur because of large numbers of passengers, nonstop flights over longer distances, delayed flights, cramped cabins, and/or alcohol consumption.1,2 Psychiatric symptoms and substance intoxication/withdrawal each represent up to 3% of all in-flight emergencies, and in most cases (90%), the primary presentation is acute anxiety.1,2 Common in-flight psychiatric differential diagnoses include depression, psychosis, personality disorders, and somatization.1

When a passenger requires medical or psychiatric treatment, the flight crew often requests aid from any trained medical professionals who are on board to augment their capabilities and resources (eg, the flight crew’s training, ground-based medical support).1 In the United States, off-duty medical professionals are not legally required to assist during an in-flight medical emergency.1 The Aviation Medical Assistance Act of 1998 protects passengers who provide medical assistance from liability, except in cases of gross negligence or willful misconduct.1,3 Flights outside of the United States are governed by a complex combination of public and private international laws.1 Here I suggest how to initiate care during in-flight psychiatric emergencies, and offer therapeutic options to employ for a passenger who is exhibiting psychiatric symptoms.

What to do first

Before volunteering to assist in a mental health emergency, consider your capabilities and limitations. Do not volunteer if you are under the influence of alcohol, illicit substances, or any medications (prescription or over-the-counter) that could affect your judgment.

Inform the flight crew that you are a mental health clinician, and outline your current clinical expertise. While the flight crew obtains the medical emergency kit, work to establish rapport with the passenger to identify the psychiatric problem and help de-escalate the situation. Initiate care by1:

  • eliciting a psychiatric history
  • inquiring about any use of alcohol, illicit substances, or other mood-altering substances (eg, type, amount, and time of use)
  • identifying any use of psychotropic medications (eg, doses, last dose taken, and if these agents are on the aircraft).

The Federal Aviation Administration has minimum requirements for the contents of medical emergency kits aboard US airlines.1,4 However, they are not required to contain antipsychotics, naloxone, or benzodiazepines.1,4 Although you may have limited medical resources at your disposal, you can still help passengers in the following ways1:

Monitor vital signs and mental status changes, identify signs and symptoms of intoxication or withdrawal, and assess for respiratory distress. Provide reassurance to the passenger if appropriate.1

Administer naloxone (if available) for suspected opioid ingestion.1 Antiemetics, which are available in these medical kits, can be used if needed. Encourage passengers to remain hydrated and use oxygen as needed.

Continue to: If verbal de-escalation is ineffective...

 

 

If verbal de-escalation is ineffective, consider administering a benzodiazepine or antipsychotic (if available).1 If the passenger is combative, refer to the flight crew for the airline’s security protocols, which may include restraining the passenger or diverting the aircraft. Safety takes priority over attempts at medical management.

If the passenger has respiratory distress, instruct the flight crew to contact ground-based medical support for additional recommendations.1

A challenging situation

Ultimately, the pilot coordinates with the flight dispatcher to manage all operational decisions for the aircraft and is responsible for decisions regarding flight diversion.1 In-flight medical volunteers, the flight crew, and ground-based medical experts can offer recommendations for care.1 Cruising at altitudes of 30,000 to 40,000 feet with limited medical equipment, often hours away from the closest medical facility, will create unfamiliar challenges for any medical professional who volunteers for in-flight psychiatric emergencies.1

References

1. Martin-Gill C, Doyle TJ, Yealy DM. In-flight medical emergencies: a review. JAMA. 2018;320(24):2580-2590.
2. Naouri D, Lapostolle F, Rondet C, et al. Prevention of medical events during air travel: a narrative review. Am J Med. 2016;129(9):1000.e1-e6.
3. Aviation Medical Assistance Act of 1998, 49 USC §44701, 105th Cong, Public Law 170 (1998).
4. Federal Aviation Administration. FAA Advisory circular No 121-33B: emergency medical equipment. https://www.faa.gov/documentLibrary/media/Advisory_Circular/AC121-33B.pdf. Published January 12, 2006. Accessed November 14, 2019.

Article PDF
Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina.

Disclosure
The author reports no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Issue
Current Psychiatry - 18(12)
Publications
Topics
Page Number
17,51
Sections
Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina.

Disclosure
The author reports no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina.

Disclosure
The author reports no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Article PDF
Article PDF

Although they are rare, in-flight psychiatric emergencies occur because of large numbers of passengers, nonstop flights over longer distances, delayed flights, cramped cabins, and/or alcohol consumption.1,2 Psychiatric symptoms and substance intoxication/withdrawal each represent up to 3% of all in-flight emergencies, and in most cases (90%), the primary presentation is acute anxiety.1,2 Common in-flight psychiatric differential diagnoses include depression, psychosis, personality disorders, and somatization.1

When a passenger requires medical or psychiatric treatment, the flight crew often requests aid from any trained medical professionals who are on board to augment their capabilities and resources (eg, the flight crew’s training, ground-based medical support).1 In the United States, off-duty medical professionals are not legally required to assist during an in-flight medical emergency.1 The Aviation Medical Assistance Act of 1998 protects passengers who provide medical assistance from liability, except in cases of gross negligence or willful misconduct.1,3 Flights outside of the United States are governed by a complex combination of public and private international laws.1 Here I suggest how to initiate care during in-flight psychiatric emergencies, and offer therapeutic options to employ for a passenger who is exhibiting psychiatric symptoms.

What to do first

Before volunteering to assist in a mental health emergency, consider your capabilities and limitations. Do not volunteer if you are under the influence of alcohol, illicit substances, or any medications (prescription or over-the-counter) that could affect your judgment.

Inform the flight crew that you are a mental health clinician, and outline your current clinical expertise. While the flight crew obtains the medical emergency kit, work to establish rapport with the passenger to identify the psychiatric problem and help de-escalate the situation. Initiate care by1:

  • eliciting a psychiatric history
  • inquiring about any use of alcohol, illicit substances, or other mood-altering substances (eg, type, amount, and time of use)
  • identifying any use of psychotropic medications (eg, doses, last dose taken, and if these agents are on the aircraft).

The Federal Aviation Administration has minimum requirements for the contents of medical emergency kits aboard US airlines.1,4 However, they are not required to contain antipsychotics, naloxone, or benzodiazepines.1,4 Although you may have limited medical resources at your disposal, you can still help passengers in the following ways1:

Monitor vital signs and mental status changes, identify signs and symptoms of intoxication or withdrawal, and assess for respiratory distress. Provide reassurance to the passenger if appropriate.1

Administer naloxone (if available) for suspected opioid ingestion.1 Antiemetics, which are available in these medical kits, can be used if needed. Encourage passengers to remain hydrated and use oxygen as needed.

Continue to: If verbal de-escalation is ineffective...

 

 

If verbal de-escalation is ineffective, consider administering a benzodiazepine or antipsychotic (if available).1 If the passenger is combative, refer to the flight crew for the airline’s security protocols, which may include restraining the passenger or diverting the aircraft. Safety takes priority over attempts at medical management.

If the passenger has respiratory distress, instruct the flight crew to contact ground-based medical support for additional recommendations.1

A challenging situation

Ultimately, the pilot coordinates with the flight dispatcher to manage all operational decisions for the aircraft and is responsible for decisions regarding flight diversion.1 In-flight medical volunteers, the flight crew, and ground-based medical experts can offer recommendations for care.1 Cruising at altitudes of 30,000 to 40,000 feet with limited medical equipment, often hours away from the closest medical facility, will create unfamiliar challenges for any medical professional who volunteers for in-flight psychiatric emergencies.1

Although they are rare, in-flight psychiatric emergencies occur because of large numbers of passengers, nonstop flights over longer distances, delayed flights, cramped cabins, and/or alcohol consumption.1,2 Psychiatric symptoms and substance intoxication/withdrawal each represent up to 3% of all in-flight emergencies, and in most cases (90%), the primary presentation is acute anxiety.1,2 Common in-flight psychiatric differential diagnoses include depression, psychosis, personality disorders, and somatization.1

When a passenger requires medical or psychiatric treatment, the flight crew often requests aid from any trained medical professionals who are on board to augment their capabilities and resources (eg, the flight crew’s training, ground-based medical support).1 In the United States, off-duty medical professionals are not legally required to assist during an in-flight medical emergency.1 The Aviation Medical Assistance Act of 1998 protects passengers who provide medical assistance from liability, except in cases of gross negligence or willful misconduct.1,3 Flights outside of the United States are governed by a complex combination of public and private international laws.1 Here I suggest how to initiate care during in-flight psychiatric emergencies, and offer therapeutic options to employ for a passenger who is exhibiting psychiatric symptoms.

What to do first

Before volunteering to assist in a mental health emergency, consider your capabilities and limitations. Do not volunteer if you are under the influence of alcohol, illicit substances, or any medications (prescription or over-the-counter) that could affect your judgment.

Inform the flight crew that you are a mental health clinician, and outline your current clinical expertise. While the flight crew obtains the medical emergency kit, work to establish rapport with the passenger to identify the psychiatric problem and help de-escalate the situation. Initiate care by1:

  • eliciting a psychiatric history
  • inquiring about any use of alcohol, illicit substances, or other mood-altering substances (eg, type, amount, and time of use)
  • identifying any use of psychotropic medications (eg, doses, last dose taken, and if these agents are on the aircraft).

The Federal Aviation Administration has minimum requirements for the contents of medical emergency kits aboard US airlines.1,4 However, they are not required to contain antipsychotics, naloxone, or benzodiazepines.1,4 Although you may have limited medical resources at your disposal, you can still help passengers in the following ways1:

Monitor vital signs and mental status changes, identify signs and symptoms of intoxication or withdrawal, and assess for respiratory distress. Provide reassurance to the passenger if appropriate.1

Administer naloxone (if available) for suspected opioid ingestion.1 Antiemetics, which are available in these medical kits, can be used if needed. Encourage passengers to remain hydrated and use oxygen as needed.

Continue to: If verbal de-escalation is ineffective...

 

 

If verbal de-escalation is ineffective, consider administering a benzodiazepine or antipsychotic (if available).1 If the passenger is combative, refer to the flight crew for the airline’s security protocols, which may include restraining the passenger or diverting the aircraft. Safety takes priority over attempts at medical management.

If the passenger has respiratory distress, instruct the flight crew to contact ground-based medical support for additional recommendations.1

A challenging situation

Ultimately, the pilot coordinates with the flight dispatcher to manage all operational decisions for the aircraft and is responsible for decisions regarding flight diversion.1 In-flight medical volunteers, the flight crew, and ground-based medical experts can offer recommendations for care.1 Cruising at altitudes of 30,000 to 40,000 feet with limited medical equipment, often hours away from the closest medical facility, will create unfamiliar challenges for any medical professional who volunteers for in-flight psychiatric emergencies.1

References

1. Martin-Gill C, Doyle TJ, Yealy DM. In-flight medical emergencies: a review. JAMA. 2018;320(24):2580-2590.
2. Naouri D, Lapostolle F, Rondet C, et al. Prevention of medical events during air travel: a narrative review. Am J Med. 2016;129(9):1000.e1-e6.
3. Aviation Medical Assistance Act of 1998, 49 USC §44701, 105th Cong, Public Law 170 (1998).
4. Federal Aviation Administration. FAA Advisory circular No 121-33B: emergency medical equipment. https://www.faa.gov/documentLibrary/media/Advisory_Circular/AC121-33B.pdf. Published January 12, 2006. Accessed November 14, 2019.

References

1. Martin-Gill C, Doyle TJ, Yealy DM. In-flight medical emergencies: a review. JAMA. 2018;320(24):2580-2590.
2. Naouri D, Lapostolle F, Rondet C, et al. Prevention of medical events during air travel: a narrative review. Am J Med. 2016;129(9):1000.e1-e6.
3. Aviation Medical Assistance Act of 1998, 49 USC §44701, 105th Cong, Public Law 170 (1998).
4. Federal Aviation Administration. FAA Advisory circular No 121-33B: emergency medical equipment. https://www.faa.gov/documentLibrary/media/Advisory_Circular/AC121-33B.pdf. Published January 12, 2006. Accessed November 14, 2019.

Issue
Current Psychiatry - 18(12)
Issue
Current Psychiatry - 18(12)
Page Number
17,51
Page Number
17,51
Publications
Publications
Topics
Article Type
Display Headline
In-flight psychiatric emergencies: What you should know
Display Headline
In-flight psychiatric emergencies: What you should know
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Dealing with deception: How to manage patients who are ‘faking it’

Article Type
Changed
Fri, 11/01/2019 - 12:36
Display Headline
Dealing with deception: How to manage patients who are ‘faking it’

Patients who fabricate or exaggerate psychiatric symptoms for primary or secondary gain may elicit negative responses from health care professionals. As clinicians, we may believe that such patients are wasting our time and taking resources away from other patients who are genuinely struggling with mental illness and are more deserving of assistance. However, patients who are fabricating or exaggerating their symptoms have legitimate clinical needs that we should strive to understand. If we view them as having reasons for their actions without becoming complicit in their deception, we may find it easier to work with them.

Managing patients who are fabricating or exaggerating

Caring for patients who attempt to mislead us is a challenging proposition. The relevant research is scarce, and there are few recommended interventions for managing patients who fabricate or exaggerate symptoms.1 Direct confrontation and accusation are often unproductive and should be used sparingly. Indirect approaches tend to be more effective.

It is important to manage our countertransference at the outset while establishing and maintaining rapport. Although we may become frustrated, we should avoid using sarcasm or overt skepticism; instead, we should validate these patients’ emotions because their emotional turmoil could be driving their fabrication or exaggeration. We should attempt to explore their specific motivations by focusing our questions on detecting the underlying stressors or conditions.2

To assess our patients’ motives, consider asking the following:

  • What kind of problems have these symptoms caused you in your day-to-day life?
  • What would make life better for you?
  • What are you hoping I can do for you today?

We should ask open-ended questions as well as interview patients over a long period of time and on multiple occasions to observe the consistency of their reported symptoms. In addition, we should take good notes and document our observations to compare what our patients tell us during their appointments.

Addressing inconsistencies

While exploring our patients’ motives, when it is appropriate, we can gently confront discrepancies in their report by asking:

  • I am confused about your symptoms. Help me understand what is happening. Can you tell me more? (Then ask specific follow-up questions based on their answer.)
  • What do you mean when you say you are experiencing this symptom?
  • I am not sure if I understand what you said correctly. These symptoms do not typically occur in the way that you described. Could you tell me more?
  • The symptoms you described are unusual to me. Is there something else going on that I am not aware of?
  • Do you think these symptoms have been coming up because you are under stress?
  • Is it possible that you want to (avoid work, avoid jail, be prescribed a specific medication, etc.) and that this is the only way you could think of to get what you need?
  • Is it possible that you are describing what you are experiencing so that you can convince others that you are having problems?

Despite our best efforts, some patients may not drop their guard and will continue to fabricate or exaggerate their symptoms. However, establishing and maintaining rapport, exploring our patients’ potential motives to mislead, and gently confronting discrepancies in their report may maximize the chances of successfully engaging them and developing appropriate treatment plans.

References

1. Brady MC, Scher LM, Newman W. “I just saw Big Bird. He was 100 feet tall!” Malingering in the emergency room. Current Psychiatry. 2013;12(10):33-40.
2. Schnellbacher S, O’Mara H. Identifying and managing malingering and factitious disorder in the military. Curr Psychiatry Rep. 2016;18(11):105.

Article PDF
Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry, and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina. Dr. Gehle is Chief Psychologist, South Carolina Department of Mental Health, Columbia, South Carolina.

Disclosures
The authors report no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Issue
Current Psychiatry - 18(11)
Publications
Page Number
16,24
Sections
Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry, and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina. Dr. Gehle is Chief Psychologist, South Carolina Department of Mental Health, Columbia, South Carolina.

Disclosures
The authors report no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry, and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina. Dr. Gehle is Chief Psychologist, South Carolina Department of Mental Health, Columbia, South Carolina.

Disclosures
The authors report no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Article PDF
Article PDF

Patients who fabricate or exaggerate psychiatric symptoms for primary or secondary gain may elicit negative responses from health care professionals. As clinicians, we may believe that such patients are wasting our time and taking resources away from other patients who are genuinely struggling with mental illness and are more deserving of assistance. However, patients who are fabricating or exaggerating their symptoms have legitimate clinical needs that we should strive to understand. If we view them as having reasons for their actions without becoming complicit in their deception, we may find it easier to work with them.

Managing patients who are fabricating or exaggerating

Caring for patients who attempt to mislead us is a challenging proposition. The relevant research is scarce, and there are few recommended interventions for managing patients who fabricate or exaggerate symptoms.1 Direct confrontation and accusation are often unproductive and should be used sparingly. Indirect approaches tend to be more effective.

It is important to manage our countertransference at the outset while establishing and maintaining rapport. Although we may become frustrated, we should avoid using sarcasm or overt skepticism; instead, we should validate these patients’ emotions because their emotional turmoil could be driving their fabrication or exaggeration. We should attempt to explore their specific motivations by focusing our questions on detecting the underlying stressors or conditions.2

To assess our patients’ motives, consider asking the following:

  • What kind of problems have these symptoms caused you in your day-to-day life?
  • What would make life better for you?
  • What are you hoping I can do for you today?

We should ask open-ended questions as well as interview patients over a long period of time and on multiple occasions to observe the consistency of their reported symptoms. In addition, we should take good notes and document our observations to compare what our patients tell us during their appointments.

Addressing inconsistencies

While exploring our patients’ motives, when it is appropriate, we can gently confront discrepancies in their report by asking:

  • I am confused about your symptoms. Help me understand what is happening. Can you tell me more? (Then ask specific follow-up questions based on their answer.)
  • What do you mean when you say you are experiencing this symptom?
  • I am not sure if I understand what you said correctly. These symptoms do not typically occur in the way that you described. Could you tell me more?
  • The symptoms you described are unusual to me. Is there something else going on that I am not aware of?
  • Do you think these symptoms have been coming up because you are under stress?
  • Is it possible that you want to (avoid work, avoid jail, be prescribed a specific medication, etc.) and that this is the only way you could think of to get what you need?
  • Is it possible that you are describing what you are experiencing so that you can convince others that you are having problems?

Despite our best efforts, some patients may not drop their guard and will continue to fabricate or exaggerate their symptoms. However, establishing and maintaining rapport, exploring our patients’ potential motives to mislead, and gently confronting discrepancies in their report may maximize the chances of successfully engaging them and developing appropriate treatment plans.

Patients who fabricate or exaggerate psychiatric symptoms for primary or secondary gain may elicit negative responses from health care professionals. As clinicians, we may believe that such patients are wasting our time and taking resources away from other patients who are genuinely struggling with mental illness and are more deserving of assistance. However, patients who are fabricating or exaggerating their symptoms have legitimate clinical needs that we should strive to understand. If we view them as having reasons for their actions without becoming complicit in their deception, we may find it easier to work with them.

Managing patients who are fabricating or exaggerating

Caring for patients who attempt to mislead us is a challenging proposition. The relevant research is scarce, and there are few recommended interventions for managing patients who fabricate or exaggerate symptoms.1 Direct confrontation and accusation are often unproductive and should be used sparingly. Indirect approaches tend to be more effective.

It is important to manage our countertransference at the outset while establishing and maintaining rapport. Although we may become frustrated, we should avoid using sarcasm or overt skepticism; instead, we should validate these patients’ emotions because their emotional turmoil could be driving their fabrication or exaggeration. We should attempt to explore their specific motivations by focusing our questions on detecting the underlying stressors or conditions.2

To assess our patients’ motives, consider asking the following:

  • What kind of problems have these symptoms caused you in your day-to-day life?
  • What would make life better for you?
  • What are you hoping I can do for you today?

We should ask open-ended questions as well as interview patients over a long period of time and on multiple occasions to observe the consistency of their reported symptoms. In addition, we should take good notes and document our observations to compare what our patients tell us during their appointments.

Addressing inconsistencies

While exploring our patients’ motives, when it is appropriate, we can gently confront discrepancies in their report by asking:

  • I am confused about your symptoms. Help me understand what is happening. Can you tell me more? (Then ask specific follow-up questions based on their answer.)
  • What do you mean when you say you are experiencing this symptom?
  • I am not sure if I understand what you said correctly. These symptoms do not typically occur in the way that you described. Could you tell me more?
  • The symptoms you described are unusual to me. Is there something else going on that I am not aware of?
  • Do you think these symptoms have been coming up because you are under stress?
  • Is it possible that you want to (avoid work, avoid jail, be prescribed a specific medication, etc.) and that this is the only way you could think of to get what you need?
  • Is it possible that you are describing what you are experiencing so that you can convince others that you are having problems?

Despite our best efforts, some patients may not drop their guard and will continue to fabricate or exaggerate their symptoms. However, establishing and maintaining rapport, exploring our patients’ potential motives to mislead, and gently confronting discrepancies in their report may maximize the chances of successfully engaging them and developing appropriate treatment plans.

References

1. Brady MC, Scher LM, Newman W. “I just saw Big Bird. He was 100 feet tall!” Malingering in the emergency room. Current Psychiatry. 2013;12(10):33-40.
2. Schnellbacher S, O’Mara H. Identifying and managing malingering and factitious disorder in the military. Curr Psychiatry Rep. 2016;18(11):105.

References

1. Brady MC, Scher LM, Newman W. “I just saw Big Bird. He was 100 feet tall!” Malingering in the emergency room. Current Psychiatry. 2013;12(10):33-40.
2. Schnellbacher S, O’Mara H. Identifying and managing malingering and factitious disorder in the military. Curr Psychiatry Rep. 2016;18(11):105.

Issue
Current Psychiatry - 18(11)
Issue
Current Psychiatry - 18(11)
Page Number
16,24
Page Number
16,24
Publications
Publications
Article Type
Display Headline
Dealing with deception: How to manage patients who are ‘faking it’
Display Headline
Dealing with deception: How to manage patients who are ‘faking it’
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

How to avoid ‘checklist’ psychiatry

Article Type
Changed
Thu, 08/22/2019 - 15:34
Display Headline
How to avoid ‘checklist’ psychiatry

To determine whether a patient meets the criteria for a DSM-5 diagnosis, we rely on objective data, direct observations, and individual biopsychosocial factors as well as our patient’s subjective report of symptoms. However, because the line differentiating normal from abnormal emotional responses can sometimes be blurred, we should be prudent when establishing a diagnosis. Specifically, we need to avoid falling into the trap of “checklist” psychiatry—relegating diagnostic assessments to robotic statements about whether patients meet DSM criteria—because this can lead to making diagnoses too quickly or inaccurately.1 Potential consequences of checklist psychiatry include1,2:

  • becoming so “married” to a particular diagnosis that you don’t consider alternative diagnoses
  • labeling patients with a diagnosis that many clinicians may view as pejorative (eg, antisocial personality disorder), which might affect their ability to receive future treatment
  • developing ineffective treatment plans based on an incorrect diagnosis, including exposing patients to medications that could have serious adverse effects
  • performing suicide or violence risk assessments based on inaccurate diagnoses, thereby over- or underestimating the possible risk for an adverse outcome
  • leading patients to assume the identity of the inaccurate diagnosis and possibly viewing themselves as dysfunctional or impaired.

When you are uncertain whether your patient has a diagnosable condition, it can be useful to use the terms “no diagnosis” or “diagnosis deferred.” However, many insurance companies will not reimburse without an actual diagnosis. Therefore, the following tips may be helpful in establishing an accurate diagnosis while avoiding checklist psychiatry.1,2

Ask patients about the degree and duration of impairment in functioning. Although impairment in functioning is a criterion of almost all DSM-5 diagnoses, not all endorsed symptoms warrant a diagnosis. Mild symptoms often resolve spontaneously over time without the need for diagnostic labels or interventions.

Make longitudinal observations. Inter­viewing patients over a long period of time and on multiple occasions can provide data on the consistency of reported symptoms, the presence or absence of behavioral correlates to reported symptomatology, the degree of impairment from the reported symptoms, and the evolution of symptoms.

Collect collateral information. Although we often rely on our patients’ reports of symptoms to establish a diagnosis, this information should not be the sole source. We can obtain a more complete picture if we approach a patient’s family members for their input, including asking about a family history of mental illness or substance use disorders. We can also review prior treatment records and gather observations from clinic or inpatient staff for additional information.

Order laboratory studies. Serum studies and urine toxicology screens provide information that can help form an accurate diagnosis. This information is helpful because certain medical conditions, substance intoxication, and substance withdrawal can mimic psychiatric symptoms.

Continuously re-evaluate your diagnoses. As clinicians, we’d like to provide an accurate diagnosis at the onset of treatment; however, this may not be realistic because the patient’s presentation might change over time. It is paramount that we view diagnoses as evolving, so that we can more readily adjust our approach to treatment, especially when the patient is not benefitting from a well-formulated and comprehensive treatment plan.

Our patients are best served when we take the necessary time to use all resources to conceptualize them as more than a checklist of symptoms.

References

1. Kontos N, Freudenreich O, Querques J. Thoughtful diagnoses: not ‘checklist’ psychiatry. Current Psychiatry. 2007;6(3):112.
2. Frances A. My 12 best tips on psychiatric diagnosis. Psychiatric Times. http://www.psychiatrictimes.com/dsm-5/my-12-best-tips-psychiatric-diagnosis. Published June 17, 2013. Accessed July 19, 2019.

Article PDF
Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina. Dr. Payne is a Forensic Psychiatry Fellow, Prisma Health, Columbia, South Carolina; and is board-certified in addiction psychiatry.

Disclosures
The authors report no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Issue
Current Psychiatry - 18(8)
Publications
Page Number
40-41
Sections
Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina. Dr. Payne is a Forensic Psychiatry Fellow, Prisma Health, Columbia, South Carolina; and is board-certified in addiction psychiatry.

Disclosures
The authors report no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina. Dr. Payne is a Forensic Psychiatry Fellow, Prisma Health, Columbia, South Carolina; and is board-certified in addiction psychiatry.

Disclosures
The authors report no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Article PDF
Article PDF

To determine whether a patient meets the criteria for a DSM-5 diagnosis, we rely on objective data, direct observations, and individual biopsychosocial factors as well as our patient’s subjective report of symptoms. However, because the line differentiating normal from abnormal emotional responses can sometimes be blurred, we should be prudent when establishing a diagnosis. Specifically, we need to avoid falling into the trap of “checklist” psychiatry—relegating diagnostic assessments to robotic statements about whether patients meet DSM criteria—because this can lead to making diagnoses too quickly or inaccurately.1 Potential consequences of checklist psychiatry include1,2:

  • becoming so “married” to a particular diagnosis that you don’t consider alternative diagnoses
  • labeling patients with a diagnosis that many clinicians may view as pejorative (eg, antisocial personality disorder), which might affect their ability to receive future treatment
  • developing ineffective treatment plans based on an incorrect diagnosis, including exposing patients to medications that could have serious adverse effects
  • performing suicide or violence risk assessments based on inaccurate diagnoses, thereby over- or underestimating the possible risk for an adverse outcome
  • leading patients to assume the identity of the inaccurate diagnosis and possibly viewing themselves as dysfunctional or impaired.

When you are uncertain whether your patient has a diagnosable condition, it can be useful to use the terms “no diagnosis” or “diagnosis deferred.” However, many insurance companies will not reimburse without an actual diagnosis. Therefore, the following tips may be helpful in establishing an accurate diagnosis while avoiding checklist psychiatry.1,2

Ask patients about the degree and duration of impairment in functioning. Although impairment in functioning is a criterion of almost all DSM-5 diagnoses, not all endorsed symptoms warrant a diagnosis. Mild symptoms often resolve spontaneously over time without the need for diagnostic labels or interventions.

Make longitudinal observations. Inter­viewing patients over a long period of time and on multiple occasions can provide data on the consistency of reported symptoms, the presence or absence of behavioral correlates to reported symptomatology, the degree of impairment from the reported symptoms, and the evolution of symptoms.

Collect collateral information. Although we often rely on our patients’ reports of symptoms to establish a diagnosis, this information should not be the sole source. We can obtain a more complete picture if we approach a patient’s family members for their input, including asking about a family history of mental illness or substance use disorders. We can also review prior treatment records and gather observations from clinic or inpatient staff for additional information.

Order laboratory studies. Serum studies and urine toxicology screens provide information that can help form an accurate diagnosis. This information is helpful because certain medical conditions, substance intoxication, and substance withdrawal can mimic psychiatric symptoms.

Continuously re-evaluate your diagnoses. As clinicians, we’d like to provide an accurate diagnosis at the onset of treatment; however, this may not be realistic because the patient’s presentation might change over time. It is paramount that we view diagnoses as evolving, so that we can more readily adjust our approach to treatment, especially when the patient is not benefitting from a well-formulated and comprehensive treatment plan.

Our patients are best served when we take the necessary time to use all resources to conceptualize them as more than a checklist of symptoms.

To determine whether a patient meets the criteria for a DSM-5 diagnosis, we rely on objective data, direct observations, and individual biopsychosocial factors as well as our patient’s subjective report of symptoms. However, because the line differentiating normal from abnormal emotional responses can sometimes be blurred, we should be prudent when establishing a diagnosis. Specifically, we need to avoid falling into the trap of “checklist” psychiatry—relegating diagnostic assessments to robotic statements about whether patients meet DSM criteria—because this can lead to making diagnoses too quickly or inaccurately.1 Potential consequences of checklist psychiatry include1,2:

  • becoming so “married” to a particular diagnosis that you don’t consider alternative diagnoses
  • labeling patients with a diagnosis that many clinicians may view as pejorative (eg, antisocial personality disorder), which might affect their ability to receive future treatment
  • developing ineffective treatment plans based on an incorrect diagnosis, including exposing patients to medications that could have serious adverse effects
  • performing suicide or violence risk assessments based on inaccurate diagnoses, thereby over- or underestimating the possible risk for an adverse outcome
  • leading patients to assume the identity of the inaccurate diagnosis and possibly viewing themselves as dysfunctional or impaired.

When you are uncertain whether your patient has a diagnosable condition, it can be useful to use the terms “no diagnosis” or “diagnosis deferred.” However, many insurance companies will not reimburse without an actual diagnosis. Therefore, the following tips may be helpful in establishing an accurate diagnosis while avoiding checklist psychiatry.1,2

Ask patients about the degree and duration of impairment in functioning. Although impairment in functioning is a criterion of almost all DSM-5 diagnoses, not all endorsed symptoms warrant a diagnosis. Mild symptoms often resolve spontaneously over time without the need for diagnostic labels or interventions.

Make longitudinal observations. Inter­viewing patients over a long period of time and on multiple occasions can provide data on the consistency of reported symptoms, the presence or absence of behavioral correlates to reported symptomatology, the degree of impairment from the reported symptoms, and the evolution of symptoms.

Collect collateral information. Although we often rely on our patients’ reports of symptoms to establish a diagnosis, this information should not be the sole source. We can obtain a more complete picture if we approach a patient’s family members for their input, including asking about a family history of mental illness or substance use disorders. We can also review prior treatment records and gather observations from clinic or inpatient staff for additional information.

Order laboratory studies. Serum studies and urine toxicology screens provide information that can help form an accurate diagnosis. This information is helpful because certain medical conditions, substance intoxication, and substance withdrawal can mimic psychiatric symptoms.

Continuously re-evaluate your diagnoses. As clinicians, we’d like to provide an accurate diagnosis at the onset of treatment; however, this may not be realistic because the patient’s presentation might change over time. It is paramount that we view diagnoses as evolving, so that we can more readily adjust our approach to treatment, especially when the patient is not benefitting from a well-formulated and comprehensive treatment plan.

Our patients are best served when we take the necessary time to use all resources to conceptualize them as more than a checklist of symptoms.

References

1. Kontos N, Freudenreich O, Querques J. Thoughtful diagnoses: not ‘checklist’ psychiatry. Current Psychiatry. 2007;6(3):112.
2. Frances A. My 12 best tips on psychiatric diagnosis. Psychiatric Times. http://www.psychiatrictimes.com/dsm-5/my-12-best-tips-psychiatric-diagnosis. Published June 17, 2013. Accessed July 19, 2019.

References

1. Kontos N, Freudenreich O, Querques J. Thoughtful diagnoses: not ‘checklist’ psychiatry. Current Psychiatry. 2007;6(3):112.
2. Frances A. My 12 best tips on psychiatric diagnosis. Psychiatric Times. http://www.psychiatrictimes.com/dsm-5/my-12-best-tips-psychiatric-diagnosis. Published June 17, 2013. Accessed July 19, 2019.

Issue
Current Psychiatry - 18(8)
Issue
Current Psychiatry - 18(8)
Page Number
40-41
Page Number
40-41
Publications
Publications
Article Type
Display Headline
How to avoid ‘checklist’ psychiatry
Display Headline
How to avoid ‘checklist’ psychiatry
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

When your patient is a physician: Overcoming the challenges

Article Type
Changed
Fri, 06/14/2019 - 09:35
Display Headline
When your patient is a physician: Overcoming the challenges

Physicians’ physical and mental well-being has become a major concern in health care. In the United States, an estimated 300 to 400 physicians die from suicide each year.1 Compared with the general population, the suicide rates for male and female physicians are 1.41 and 2.27 times higher, respectively.2 As psychiatrists, we can play an instrumental role in preserving our colleagues’ mental health. While treating a fellow physician can be rewarding, these situations also can be challenging. Here we describe a few of the challenges of treating physicians, and solutions we can employ to minimize potential pitfalls.

Challenges: How our relationship can affect care

We may view physician-patients as “VIPs” because of their profession, which might lead us to assume they are more knowledgeable than the average patient.1,3 This mindset could result in taking an inadequate history, having an incomplete informed-consent discussion, avoiding or limiting educational discussions, performing an inadequate suicide risk assessment, or underestimating the need for higher levels of care (eg, psychiatric hospitalization).1

We may have difficulty maintaining appropriate professional boundaries due to the relationship (eg, friend, colleague, or mentor) we have established with a physician-patient.3 It may be difficult to establish the usual roles of patient and physician, particularly if we have a professional relationship with a physician-patient that requires routine contact at work. The issue of boundaries can become compounded if there is an emotional component to the relationship, which may make it difficult to discuss sensitive topics.3 A physician-patient may be reluctant to discuss sensitive information due to concerns about the confidentiality of their medical record.3 They also might obtain our personal contact information through work-related networks and use it to contact us about their care.

 

Solutions: Treat them as you would any other patient

Although physician-patients may have more medical knowledge than other patients, we should avoid showing deference and making assumptions about their knowledge of psychiatric illnesses and treatment. As we would with other patients, we should always1:

  • conduct a thorough evaluation
  • develop a comprehensive treatment plan
  • provide appropriate informed consent
  • adequately assess suicide risk.

We should also maintain boundaries as best we can, while understanding that our professional relationships might complicate this.

We should ask our physician-patients if they have been self-prescribing and/or self-treating.1 We shouldn’t shy away from considering inpatient treatment for physician-patients (when clinically indicated) because of our concern that such treatment might jeopardize their ability to practice medicine. Also, to help decrease barriers to and enhance engagement in treatment, consider recommending treatment options that can take place outside of the physician-patient’s work environment.3

Continue to: We should provide...

 

 

We should provide the same confidentiality considerations to physician-patients as we do to other patients. However, at times, we may need to break confidentiality for safety concerns or reporting that is required by law. We may have to contact a state licensing board if a physician-patient continues to practice while impaired despite engaging in treatment.1 We should understand the procedures for reporting; have referral resources available for these patients, such as recovering physician programs; and know whom to contact for further counsel, such as risk management or legal teams.1

The best way to provide optimal psychiatric care to a physician colleague is to acknowledge the potential challenges at the onset of treatment, and work collaboratively to avoid the potential pitfalls during the course of treatment.

References

1. Fischer-Sanchez D. Risk management considerations when treating fellow physicians. Psychiatric News. https://psychnews.psychiatryonline.org/doi/10.1176/appi.pn.2018.7a21. Published July 3, 2018. Accessed May 9, 2019.

Article PDF
Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina. Dr. Jones is Associate Professor of Clinical Psychiatry, Adjunct Associate Professor of Clinical Obstetrics and Gynecology, and Director, General Psychiatry Residency, Prisma Health, Columbia, South Carolina.

Disclosures
Dr. Joshi reports no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products. Dr. Jones receives financial compensation from Alpha Genomix Laboratories for her clinical time as a Principal Investigator on a study related to pharmacogenomics.

Issue
Current Psychiatry - 18(6)
Publications
Topics
Page Number
9,51
Sections
Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina. Dr. Jones is Associate Professor of Clinical Psychiatry, Adjunct Associate Professor of Clinical Obstetrics and Gynecology, and Director, General Psychiatry Residency, Prisma Health, Columbia, South Carolina.

Disclosures
Dr. Joshi reports no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products. Dr. Jones receives financial compensation from Alpha Genomix Laboratories for her clinical time as a Principal Investigator on a study related to pharmacogenomics.

Author and Disclosure Information

Dr. Joshi is Associate Professor of Clinical Psychiatry and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina. Dr. Jones is Associate Professor of Clinical Psychiatry, Adjunct Associate Professor of Clinical Obstetrics and Gynecology, and Director, General Psychiatry Residency, Prisma Health, Columbia, South Carolina.

Disclosures
Dr. Joshi reports no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products. Dr. Jones receives financial compensation from Alpha Genomix Laboratories for her clinical time as a Principal Investigator on a study related to pharmacogenomics.

Article PDF
Article PDF

Physicians’ physical and mental well-being has become a major concern in health care. In the United States, an estimated 300 to 400 physicians die from suicide each year.1 Compared with the general population, the suicide rates for male and female physicians are 1.41 and 2.27 times higher, respectively.2 As psychiatrists, we can play an instrumental role in preserving our colleagues’ mental health. While treating a fellow physician can be rewarding, these situations also can be challenging. Here we describe a few of the challenges of treating physicians, and solutions we can employ to minimize potential pitfalls.

Challenges: How our relationship can affect care

We may view physician-patients as “VIPs” because of their profession, which might lead us to assume they are more knowledgeable than the average patient.1,3 This mindset could result in taking an inadequate history, having an incomplete informed-consent discussion, avoiding or limiting educational discussions, performing an inadequate suicide risk assessment, or underestimating the need for higher levels of care (eg, psychiatric hospitalization).1

We may have difficulty maintaining appropriate professional boundaries due to the relationship (eg, friend, colleague, or mentor) we have established with a physician-patient.3 It may be difficult to establish the usual roles of patient and physician, particularly if we have a professional relationship with a physician-patient that requires routine contact at work. The issue of boundaries can become compounded if there is an emotional component to the relationship, which may make it difficult to discuss sensitive topics.3 A physician-patient may be reluctant to discuss sensitive information due to concerns about the confidentiality of their medical record.3 They also might obtain our personal contact information through work-related networks and use it to contact us about their care.

 

Solutions: Treat them as you would any other patient

Although physician-patients may have more medical knowledge than other patients, we should avoid showing deference and making assumptions about their knowledge of psychiatric illnesses and treatment. As we would with other patients, we should always1:

  • conduct a thorough evaluation
  • develop a comprehensive treatment plan
  • provide appropriate informed consent
  • adequately assess suicide risk.

We should also maintain boundaries as best we can, while understanding that our professional relationships might complicate this.

We should ask our physician-patients if they have been self-prescribing and/or self-treating.1 We shouldn’t shy away from considering inpatient treatment for physician-patients (when clinically indicated) because of our concern that such treatment might jeopardize their ability to practice medicine. Also, to help decrease barriers to and enhance engagement in treatment, consider recommending treatment options that can take place outside of the physician-patient’s work environment.3

Continue to: We should provide...

 

 

We should provide the same confidentiality considerations to physician-patients as we do to other patients. However, at times, we may need to break confidentiality for safety concerns or reporting that is required by law. We may have to contact a state licensing board if a physician-patient continues to practice while impaired despite engaging in treatment.1 We should understand the procedures for reporting; have referral resources available for these patients, such as recovering physician programs; and know whom to contact for further counsel, such as risk management or legal teams.1

The best way to provide optimal psychiatric care to a physician colleague is to acknowledge the potential challenges at the onset of treatment, and work collaboratively to avoid the potential pitfalls during the course of treatment.

Physicians’ physical and mental well-being has become a major concern in health care. In the United States, an estimated 300 to 400 physicians die from suicide each year.1 Compared with the general population, the suicide rates for male and female physicians are 1.41 and 2.27 times higher, respectively.2 As psychiatrists, we can play an instrumental role in preserving our colleagues’ mental health. While treating a fellow physician can be rewarding, these situations also can be challenging. Here we describe a few of the challenges of treating physicians, and solutions we can employ to minimize potential pitfalls.

Challenges: How our relationship can affect care

We may view physician-patients as “VIPs” because of their profession, which might lead us to assume they are more knowledgeable than the average patient.1,3 This mindset could result in taking an inadequate history, having an incomplete informed-consent discussion, avoiding or limiting educational discussions, performing an inadequate suicide risk assessment, or underestimating the need for higher levels of care (eg, psychiatric hospitalization).1

We may have difficulty maintaining appropriate professional boundaries due to the relationship (eg, friend, colleague, or mentor) we have established with a physician-patient.3 It may be difficult to establish the usual roles of patient and physician, particularly if we have a professional relationship with a physician-patient that requires routine contact at work. The issue of boundaries can become compounded if there is an emotional component to the relationship, which may make it difficult to discuss sensitive topics.3 A physician-patient may be reluctant to discuss sensitive information due to concerns about the confidentiality of their medical record.3 They also might obtain our personal contact information through work-related networks and use it to contact us about their care.

 

Solutions: Treat them as you would any other patient

Although physician-patients may have more medical knowledge than other patients, we should avoid showing deference and making assumptions about their knowledge of psychiatric illnesses and treatment. As we would with other patients, we should always1:

  • conduct a thorough evaluation
  • develop a comprehensive treatment plan
  • provide appropriate informed consent
  • adequately assess suicide risk.

We should also maintain boundaries as best we can, while understanding that our professional relationships might complicate this.

We should ask our physician-patients if they have been self-prescribing and/or self-treating.1 We shouldn’t shy away from considering inpatient treatment for physician-patients (when clinically indicated) because of our concern that such treatment might jeopardize their ability to practice medicine. Also, to help decrease barriers to and enhance engagement in treatment, consider recommending treatment options that can take place outside of the physician-patient’s work environment.3

Continue to: We should provide...

 

 

We should provide the same confidentiality considerations to physician-patients as we do to other patients. However, at times, we may need to break confidentiality for safety concerns or reporting that is required by law. We may have to contact a state licensing board if a physician-patient continues to practice while impaired despite engaging in treatment.1 We should understand the procedures for reporting; have referral resources available for these patients, such as recovering physician programs; and know whom to contact for further counsel, such as risk management or legal teams.1

The best way to provide optimal psychiatric care to a physician colleague is to acknowledge the potential challenges at the onset of treatment, and work collaboratively to avoid the potential pitfalls during the course of treatment.

References

1. Fischer-Sanchez D. Risk management considerations when treating fellow physicians. Psychiatric News. https://psychnews.psychiatryonline.org/doi/10.1176/appi.pn.2018.7a21. Published July 3, 2018. Accessed May 9, 2019.

References

1. Fischer-Sanchez D. Risk management considerations when treating fellow physicians. Psychiatric News. https://psychnews.psychiatryonline.org/doi/10.1176/appi.pn.2018.7a21. Published July 3, 2018. Accessed May 9, 2019.

Issue
Current Psychiatry - 18(6)
Issue
Current Psychiatry - 18(6)
Page Number
9,51
Page Number
9,51
Publications
Publications
Topics
Article Type
Display Headline
When your patient is a physician: Overcoming the challenges
Display Headline
When your patient is a physician: Overcoming the challenges
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Helping patients through a benzodiazepine taper

Article Type
Changed
Thu, 01/16/2020 - 16:07
Display Headline
Helping patients through a benzodiazepine taper

Benzodiazepines are one of the most commonly prescribed medication classes worldwide.1 Patients prescribed benzodiazepines who have no history of abuse or misuse may want to reduce or discontinue using these agents for various reasons, including adverse effects or wanting to reduce the number of medications they take. In this article, we offer strategies for creating an individualized taper plan, and describe additional nonpharmacologic interventions to help ensure that the taper is successful.

Formulating a taper plan

There is no gold-standard algorithm for tapering benzodiazepines.1,2 Even with a carefully designed plan, tapering can be challenging because approximately one-third of patients will experience difficulties such as withdrawal symptoms.1 Prior to creating a plan, carefully assess the patient’s history, including the type of benzodiazepine prescribed (short- or long-acting); the dose, dosing frequency, and duration of use; comorbid medical and psychiatric conditions; any previous experience with withdrawal symptoms; and psychosocial factors (eg, lifestyle and personality). Consider whether the patient can be safely tapered in an outpatient setting or will require hospitalization. Tapering designed to take place over several weeks or months tends to be more successful; however, patient-specific circumstances play a role in determining the duration of the taper.1,2

For the greatest chance of success, a benzodiazepine should not be reduced faster than 25% of the total daily dose per week.1 Consider which of the following pharmacologic approaches to benzodiazepine tapering might work best for your patient:

  • Reduce the daily dose by one-eighth to one-tenth every 1 to 2 weeks over a 2- to 12-month period for patients with a physiological dependence.1
  • Reduce the benzodiazepine dose by 10% to 25% every 2 weeks over a 4- to 8-week period.2
  • Some guidelines have suggested converting the prescribed benzodiazepine to an equivalent dose of diazepam because of its long half-life, and then reducing the diazepam dose by one-eighth every 2 weeks.3

There is uncertainty in the medical literature about using a long-acting benzodiazepine to taper off a short-acting benzodiazepine, although this practice is generally clinically accepted.1,2 Similarly, there is no definitive evidence that supports using adjuvant medications to facilitate tapering.1,2

Nonpharmacologic interventions

Patients are more likely to have a successful taper if nonpharmacologic interventions are part of a comprehensive treatment plan.1

To help your patients through the challenges of a benzodiazepine taper:

  • Validate their concerns, reassure them that you will support them throughout the taper, and provide information on additional resources for support.
  • Provide education about the process of tapering and symptoms of withdrawal.
  • Recommend therapies, such as cognitive-behavioral therapy or motivational interventions, that develop or enhance coping skills.
  • Enlist the help of the patient’s family and friends for support and encouragement.

Despite some clinicians’ trepidation, 70% to 90% of patients can be successfully tapered off benzodiazepines by using an individualized approach that includes tailored tapering and nonpharmacologic interventions that provide benefits that persist after the patient completes the taper.1

References

1. Guina J, Merrill B. Benzodiazepines II: waking up on sedatives: providing optimal care when inheriting benzodiazepine prescriptions in transfer patients. J Clin Med. 2018;7(2):pii: E20. doi: 10.3390/jcm7020020.
2. Soyka M. Treatment of benzodiazepine dependence. N Engl J Med. 2017;376(12):1147-1157.
3. Diaper AM, Law FD, Melichar JK. Pharmacological strategies for detoxification. Br J Clin Pharmacol. 2014;77(2):302-314.

Article PDF
Author and Disclosure Information

Dr. Payne is a Forensic Psychiatry Fellow, Palmetto Health, Columbia, South Carolina; and is board-certified in addiction psychiatry. Dr. Joshi is Associate Professor of Clinical Psychiatry and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina.

Disclosures
The authors report no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Issue
Current Psychiatry - 18(3)
Publications
Topics
Page Number
9-10
Sections
Author and Disclosure Information

Dr. Payne is a Forensic Psychiatry Fellow, Palmetto Health, Columbia, South Carolina; and is board-certified in addiction psychiatry. Dr. Joshi is Associate Professor of Clinical Psychiatry and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina.

Disclosures
The authors report no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Author and Disclosure Information

Dr. Payne is a Forensic Psychiatry Fellow, Palmetto Health, Columbia, South Carolina; and is board-certified in addiction psychiatry. Dr. Joshi is Associate Professor of Clinical Psychiatry and Associate Director, Forensic Psychiatry Fellowship, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina.

Disclosures
The authors report no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Article PDF
Article PDF

Benzodiazepines are one of the most commonly prescribed medication classes worldwide.1 Patients prescribed benzodiazepines who have no history of abuse or misuse may want to reduce or discontinue using these agents for various reasons, including adverse effects or wanting to reduce the number of medications they take. In this article, we offer strategies for creating an individualized taper plan, and describe additional nonpharmacologic interventions to help ensure that the taper is successful.

Formulating a taper plan

There is no gold-standard algorithm for tapering benzodiazepines.1,2 Even with a carefully designed plan, tapering can be challenging because approximately one-third of patients will experience difficulties such as withdrawal symptoms.1 Prior to creating a plan, carefully assess the patient’s history, including the type of benzodiazepine prescribed (short- or long-acting); the dose, dosing frequency, and duration of use; comorbid medical and psychiatric conditions; any previous experience with withdrawal symptoms; and psychosocial factors (eg, lifestyle and personality). Consider whether the patient can be safely tapered in an outpatient setting or will require hospitalization. Tapering designed to take place over several weeks or months tends to be more successful; however, patient-specific circumstances play a role in determining the duration of the taper.1,2

For the greatest chance of success, a benzodiazepine should not be reduced faster than 25% of the total daily dose per week.1 Consider which of the following pharmacologic approaches to benzodiazepine tapering might work best for your patient:

  • Reduce the daily dose by one-eighth to one-tenth every 1 to 2 weeks over a 2- to 12-month period for patients with a physiological dependence.1
  • Reduce the benzodiazepine dose by 10% to 25% every 2 weeks over a 4- to 8-week period.2
  • Some guidelines have suggested converting the prescribed benzodiazepine to an equivalent dose of diazepam because of its long half-life, and then reducing the diazepam dose by one-eighth every 2 weeks.3

There is uncertainty in the medical literature about using a long-acting benzodiazepine to taper off a short-acting benzodiazepine, although this practice is generally clinically accepted.1,2 Similarly, there is no definitive evidence that supports using adjuvant medications to facilitate tapering.1,2

Nonpharmacologic interventions

Patients are more likely to have a successful taper if nonpharmacologic interventions are part of a comprehensive treatment plan.1

To help your patients through the challenges of a benzodiazepine taper:

  • Validate their concerns, reassure them that you will support them throughout the taper, and provide information on additional resources for support.
  • Provide education about the process of tapering and symptoms of withdrawal.
  • Recommend therapies, such as cognitive-behavioral therapy or motivational interventions, that develop or enhance coping skills.
  • Enlist the help of the patient’s family and friends for support and encouragement.

Despite some clinicians’ trepidation, 70% to 90% of patients can be successfully tapered off benzodiazepines by using an individualized approach that includes tailored tapering and nonpharmacologic interventions that provide benefits that persist after the patient completes the taper.1

Benzodiazepines are one of the most commonly prescribed medication classes worldwide.1 Patients prescribed benzodiazepines who have no history of abuse or misuse may want to reduce or discontinue using these agents for various reasons, including adverse effects or wanting to reduce the number of medications they take. In this article, we offer strategies for creating an individualized taper plan, and describe additional nonpharmacologic interventions to help ensure that the taper is successful.

Formulating a taper plan

There is no gold-standard algorithm for tapering benzodiazepines.1,2 Even with a carefully designed plan, tapering can be challenging because approximately one-third of patients will experience difficulties such as withdrawal symptoms.1 Prior to creating a plan, carefully assess the patient’s history, including the type of benzodiazepine prescribed (short- or long-acting); the dose, dosing frequency, and duration of use; comorbid medical and psychiatric conditions; any previous experience with withdrawal symptoms; and psychosocial factors (eg, lifestyle and personality). Consider whether the patient can be safely tapered in an outpatient setting or will require hospitalization. Tapering designed to take place over several weeks or months tends to be more successful; however, patient-specific circumstances play a role in determining the duration of the taper.1,2

For the greatest chance of success, a benzodiazepine should not be reduced faster than 25% of the total daily dose per week.1 Consider which of the following pharmacologic approaches to benzodiazepine tapering might work best for your patient:

  • Reduce the daily dose by one-eighth to one-tenth every 1 to 2 weeks over a 2- to 12-month period for patients with a physiological dependence.1
  • Reduce the benzodiazepine dose by 10% to 25% every 2 weeks over a 4- to 8-week period.2
  • Some guidelines have suggested converting the prescribed benzodiazepine to an equivalent dose of diazepam because of its long half-life, and then reducing the diazepam dose by one-eighth every 2 weeks.3

There is uncertainty in the medical literature about using a long-acting benzodiazepine to taper off a short-acting benzodiazepine, although this practice is generally clinically accepted.1,2 Similarly, there is no definitive evidence that supports using adjuvant medications to facilitate tapering.1,2

Nonpharmacologic interventions

Patients are more likely to have a successful taper if nonpharmacologic interventions are part of a comprehensive treatment plan.1

To help your patients through the challenges of a benzodiazepine taper:

  • Validate their concerns, reassure them that you will support them throughout the taper, and provide information on additional resources for support.
  • Provide education about the process of tapering and symptoms of withdrawal.
  • Recommend therapies, such as cognitive-behavioral therapy or motivational interventions, that develop or enhance coping skills.
  • Enlist the help of the patient’s family and friends for support and encouragement.

Despite some clinicians’ trepidation, 70% to 90% of patients can be successfully tapered off benzodiazepines by using an individualized approach that includes tailored tapering and nonpharmacologic interventions that provide benefits that persist after the patient completes the taper.1

References

1. Guina J, Merrill B. Benzodiazepines II: waking up on sedatives: providing optimal care when inheriting benzodiazepine prescriptions in transfer patients. J Clin Med. 2018;7(2):pii: E20. doi: 10.3390/jcm7020020.
2. Soyka M. Treatment of benzodiazepine dependence. N Engl J Med. 2017;376(12):1147-1157.
3. Diaper AM, Law FD, Melichar JK. Pharmacological strategies for detoxification. Br J Clin Pharmacol. 2014;77(2):302-314.

References

1. Guina J, Merrill B. Benzodiazepines II: waking up on sedatives: providing optimal care when inheriting benzodiazepine prescriptions in transfer patients. J Clin Med. 2018;7(2):pii: E20. doi: 10.3390/jcm7020020.
2. Soyka M. Treatment of benzodiazepine dependence. N Engl J Med. 2017;376(12):1147-1157.
3. Diaper AM, Law FD, Melichar JK. Pharmacological strategies for detoxification. Br J Clin Pharmacol. 2014;77(2):302-314.

Issue
Current Psychiatry - 18(3)
Issue
Current Psychiatry - 18(3)
Page Number
9-10
Page Number
9-10
Publications
Publications
Topics
Article Type
Display Headline
Helping patients through a benzodiazepine taper
Display Headline
Helping patients through a benzodiazepine taper
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media